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Abstract
Severe maternal morbidity (SMM) rates in Michigan have increased over the past 20
years and continue to affect racial and ethnic women disproportionately. Women
experiencing health conditions that complicate pregnancy outcomes have a greater risk of
having poor obstetric outcomes that result in a SMM event. To evaluate the distribution
of women experiencing health conditions that complicate pregnancy and a SMM event,
geographic information systems were utilized in this study. The purpose of this study was
to depict trends in the prevalence of 4 health conditions and SMM among women
hospitalized for obstetric delivery in Michigan from 2016–2017. The 4 health conditions
associated with pregnancy complications were obesity, hypertension, mental health
diagnosis, and diabetes. This study was supported by the socio-ecological model and the
critical race framework that advance the idea that an individual’s health is a consequence
of the environment, structural and intrapersonal factors, and the community where they
live and seek healthcare services. A retrospective cohort analysis was conducted using
the 2016–2017 State Inpatient Database, which is the largest database for delivery
hospitalizations with race and ethnicity included. Logistical regression analysis indicated
an association with geographic location and race and ethnicity, which were the
sociodemographic predictors related to SMM risk. The analysis provided detailed
information on the locations with the greatest need for more comprehensive maternal
health interventions. This study contributes to social change by focusing on improving
the health of women, who are of childbearing age, through equitable interventions that
address disparities in SMM.
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Section 1: Foundation of the Study and Literature Review
Introduction
Maternal health has become a prominent news story due to the recent increases in
mortality and morbidity. The World Health Organization estimated that over 300,000
women died globally from pregnancy complications and that the worldwide maternal
mortality rate has dropped 44% since 1990; yet, in the United States, the maternal
mortality rate has increased during that time. The United States is 1 of 8 countries that
has experienced an increase in maternal mortality, ranking at the bottom of all developed
countries (Hirshberg & Srinivas, 2017; WHO, 2015b). Maternal mortality is the death of
a woman within 1 year of the end of pregnancy related to pregnancy or pregnancy
management, whereas morbidity is unexpected outcomes from labor and delivery
complications that can result in consequences to a woman’s health (Centers for Disease
Control and Prevention [CDC], 2017b). Maternal mortality rates proxy the quality and
effectiveness of a nation’s healthcare overall, and upon further analysis brings to light
disparities within the healthcare system.
In the United States, approximately 700 women die per year from pregnancyrelated complications, and approximately 60% of those deaths are preventable (Peterson
et al., 2019). Maternal mortality rates hover between 21–22 deaths per 100,000 live births
(Moaddab et al., 2018). In Michigan, approximately 90 women die each year during the
antepartum, intrapartum, or postpartum periods, which translate to about 9 deaths per
100,000 live births (Michigan Maternal Mortality Surveillance Program [MMMS], 2018).
While this may be lower than the national rate, it has highlighted disparate outcomes for
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racial and ethnic women (Michigan Department of Health and Human Services Division
for Vital Records & Health Statistics, 2018).
The most common cause of pregnancy-related deaths in Michigan is
cardiomyopathy (21%), followed by infection/sepsis (14%; MMMS, 2018). Less
common but significant causes of death include cardiovascular conditions, amniotic fluid
embolism, hypertension, and other medical conditions (primarily due to chronic diseases,
such as cancer, epilepsy, and diabetes; MMMS, 2018). The most common cause of
pregnancy-associated, but not related (i.e., injury), deaths is accidental poisoning/drug
overdose (45%; MMMS, 2018). Other common causes of death include motor vehicle
accidents (23%), homicide (16%), and suicide (11%; MMMS, 2018). According to the
Michigan Pregnancy Risk Monitoring System (PRAMS, 2017) and resident live birth
files from the Division for Vital Records and Health Statistics, in 2017, 52.4% of women
delivering an infant entered pregnancy overweight or obese. The racial and ethnic
disparities seen nationally are also patterned and observed in Michigan. From 2011–
2015, Black women were 3 times more likely to die from pregnancy-related causes in
Michigan (27.7 versus 8.1 per 100,000 live births, respectively; MMMS, 2018). For the
same timeframe, Black women were twice as likely to die from pregnancy-associated, not
pregnancy-related, causes compared to White women (MMMS, 2018).
Maternal morbidity and mortality, as well as the accompanying unintended
outcomes, have been steadily increasing, gaining global, national, and statewide
attention. Maternal mortality and morbidity are representations of the nation’s overall
health and well-being of its citizens. Providing adequate care to women and children can

3
indicate how a nation, state, or local community takes care of the population at large.
Poor health outcomes and the associated complications have detrimental effects on the
mother, infant, and families affected by maternal mortality and morbidity. While it is
important to note that the increase in maternal mortality and morbidity is attributed to
improved surveillance, it can be linked to increasing prevalence of obesity and chronic
health conditions (MacDorman, Declercq, Cabral & Morton, 2016). The CDC (2017b)
has documented other potential risk factors such as maternal age (i.e., > 35 years old);
women living in medically underserved or rural areas; and cesarean delivery, which may
affect women differently (Kilpatrick, Ecker, & American College of Obstetricians and
Gynecologists, 2016). Moreover, significant racial and ethnic disparities exist, especially
for non-Hispanic Black women, who are 3 to 4 times more likely to die from
complications related to pregnancy when compared to non-Hispanic White women
(Admon et al., 2018; Creanga, Syverson, Seed, & Callaghan, 2017).
Maternal mortality, although catastrophic, affects fewer women in the United
States than severe maternal morbidity (SMM). Maternal morbidity affects more than
60,000 women annually in the United States and is associated with high costs and
disability (Chen, Chauhan, & Blackwell, 2018; Silveira et al., 2016). Due to the higher
frequency of morbidity, the analysis and review of SMM events have the potential to be
more informative for policy and practice. SMM, which is based on a specific set of
inclusion criteria outlined by the CDC (discussed later in the study), is defined by any
health condition attributed to and/or complication of pregnancy and childbirth that has a
negative impact on a woman’s well-being and functioning and is described per 10,000
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delivery hospitalizations (CDC, 2017b; Chou et al., 2016). The effects of maternal
morbidity have a negative impact on a women’s well-being, family function, and an
infant’s trajectory, which highlights the need for a comprehensive evaluation of the
maternal morbidity burden. In response to these increasing trends, the WHO created the
Maternal Morbidity Working Group to craft standardized definitions and measurement
criteria (Machiyama et al., 2017). The mission of this group is to shift the focus from
maternal mortality and move upstream to focus on women surviving childbirth with a
morbid event (WHO, 2015a). This shift emphasizes the need for more robust systemic
changes that focus on the entire life course. Researchers continue to study the collective
impact on women’s function postmaternal morbid event and, therefore, require better
understanding and more innovative analysis (Silveira et al., 2016).
The Michigan Mortality Surveillance Committee, which is the nation’s longest
standing mortality surveillance committee, has identified priority areas for the reduction
of maternal mortality and morbidity (MMMS, 2018). In 2018, the Committee identified
access to care, prenatal care, mental health, and a healthy lifestyle as the leading priority
areas (Michigan Department of Health and Human Services Division for Vital Records &
Health Statistics, 2018). The identification of priority areas within women’s health during
preconception, perinatal, and postpartum may vary geographically across the state. Due
to the striking variation regarding population density and geography across the state of
Michigan, the recommendations vary widely due to resources and availability (MMMS,
2018). This became apparent when evaluating existing metrics, such as neonatal
abstinence syndrome, resulting from increased opioid use during pregnancy, where
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Michigan’s rural areas have been disproportionately affected by this epidemic (CMS,
2019; Michigan Department of Health and Human Services Division for Vital Records &
Health Statistics, 2018). Enhanced tracking of SMM is one way to identify priority areas
for interventions, quality improvement, and effective interventions. This aligns with
reports from the CDC; other state’s Maternal Mortality Review Committees; and the
Preventing Maternal Deaths Act of 2018, which emphasizes the need for identification
and analysis of maternal death and morbidity at the state level (CDC, 2016).
Recently, national findings have associated the risk of SMM with geographic
location, race and ethnicity, and chronic or preexisting health conditions (Admon et al.,
2018; CDC, 2016; Chen et al., 2018; Silveira et al., 2016; Somer, Sinkey, & Bryant,
2017). Black women die from pregnancy-related causes at higher rates when compared to
White women, which is reflected in Michigan’s SMM rates (MMMS, 2018; Petersen et
al., 2019). Those disproportionate rates are aggravated when chronic conditions are added
to the analysis and affect racial and ethnic women disproportionately (Admon et al.,
2018; Somer et al., 2017). Increasing rates of preexisting, chronic conditions within racial
and ethnic women demonstrate inequitable care despite the advances in transportation,
medical technologies, and health policy (Creanga et al., 2017; Louis, Menard & Gee,
2015; Somer et al., 2017). Women living in rural communities have experienced greater
rates of SMM, including higher rates of eclampsia (Lisonkova et al., 2016). Moreover, it
is important to note that the effects of morbidity not only manifest in physical chronic
conditions but as a mental and behavioral health risk. Machiyama et al. (2017) found
SMM was associated with depression, diabetes, and incontinence among other burdens of
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ill health, such as mental, social, economic, marital, and sexual functioning. Maternal
depression and anxiety contribute to the rising numbers of maternal morbidity yet has
been underreported and often overlooked in current literature. These disproportionate
health outcomes have been associated with higher medical costs, extended hospital stays,
and excess trauma for women and families (Chen et al., 2018; Silveira et al., 2016).
Examining the impact of geographic location, race and ethnicity, and health conditions
associated with pregnancy complications have on delivery hospitalization in Michigan
will impact the lives of its residents and reduce the healthcare burden on providers and
patients.
Problem Statement
While maternal mortality is a sentinel event, SMM affects more than 50,000
women per year, which is 100 times more frequent than maternal mortality (CDC,
2017b). SMM is the unexpected outcome(s) of a delivery hospitalization that has shortand/or long-term complications (CDC, 2017b). The rates of SMM have been steadily
increasing in the United States and Michigan for women of color, women living in
resource-poor communities, and women living with preexisting health conditions (CDC,
2017b). The burden of maternal morbidity has been discussed as the bottom, larger, and
more dangerous part of the public health issue with more complicated pathologies. In
2017, the Michigan SMM rate among all hospital deliveries was 1.7 per 10,000 delivery
hospitalizations and affected racial and ethnic populations disproportionately: 1.4 for
non-Hispanic White women, 1.42 for Native American women, 1.55 for Hispanic
women, Asian women 1.67, and 2.77 for African American women (Michigan Alliance
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for Innovation on Maternal Health, 2019). The consequences of increasing SMM rates on
a women’s health are wide-ranging and complex. Understanding the patterns by
geographic locations, race and ethnicity, and health conditions associated with pregnancy
complications are essential to reducing the burden of SMM.
Michigan is divided into 10 prosperity regions consisting of 83 counties and more
than 1,100 zip codes (PRAMS, 2017). There are gaps in understanding the variability
between zip codes and adverse maternal health outcomes, specifically racial and ethnic
women living with health conditions that complicate pregnancy. It is important for the
development of zip code level interventions to promote optimal health for women.
Reliable and up to date zip code level data are essential to monitor widening inequities to
inform innovative policies and programs that halt the disparities and manage the increase
morbidity burden. In an effort to provide more statewide information, the purpose of this
study was to describe SMM by geographic location, racial and ethnic women, and health
condition.
Purpose of the Study
The purpose of this exploratory, retrospective cohort study was to describe SMM
disparities during delivery hospitalizations in Michigan from 2016–2017. The highest
burden of SMM clusters where health systems are weakest, the environment is resourcepoor, and individuals are living in the most vulnerable communities; the burden
disproportionately falls on the most vulnerable women (Graham et al., 2016). The highrisk conditions are generally undiagnosed or mismanaged chronic conditions that
contribute to poor obstetric conditions (CDC, 2016). The variation in the prevalence of
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chronic conditions, by race and ethnicity, has not been comprehensively examined in a
statewide sample of delivering women. The health disparities among racial and ethnic
groups experiencing poorer health outcomes prompted a deeper analysis into the specific
locations these events are occurring to provide access to adequate health care,
contraception counseling, prenatal and postpartum care, and improvement in tailored
public health interventions.
In this study, I compared maternal morbidity among geographic location, race and
ethnicity, and health conditions associated with pregnancy complications associated with
SMM outcomes. Using ArcGIS software for geographic, spatial reference and analysis
provided a better understanding where persistent maternal and pregnancy related health
issues occur in Michigan. This approach was unique insofar as I described the
characteristics of the population by (a) SMM, (b) geographic location, (c) race and
ethnicity, and (d) health condition impacting pregnancy outcomes. Furthermore, the
conditions associated with greater socioeconomic and health-access disparities were
explicated.
Makanga, Schuurman, von Dadelszen, and Firoz (2016) urged researchers to
develop a spatial analysis that would inform the geographical variation in risk factors on
adverse maternal outcomes to better inform practitioners. There is limited Geographic
Information Systems (GIS) evidence that exists, and more explicit use of this technology
can account for geographical variation in Michigan. The analysis promoted a call to
action for those striving to improve access to healthcare services prior to delivery for
women living in Michigan’s most vulnerable communities. This study provides an
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opportunity for public health personnel to understand the health disparities in SMM rates,
including preexisting conditions, preconception health, and access to women’s health
services. The findings of this study may shed light on the geographic variation and
disparities for women and provide a unique opportunity for improvement in coordinated
services to manage chronic conditions prior to pregnancy.
Currently, geographic disparities in SMM have not been adequately examined; for
example, knowing where there are greater rates of obesity and a SMM event in a specific
zip code will help prompt public health interventions to become more tailored, timely,
and poignant. Addressing SMM after pregnancy is less timely and unlikely to have
lasting effects; however, providing care for a preexisting medical condition prior to
pregnancy and birth may become more sufficient in preventing an event, considering
50% of pregnancies in the United States are unplanned (Metcalf, Wick, & Ronksley,
2018). Depicting these rates will help notify public health professionals of the areas with
the greatest need. The use of GIS to demonstrate geographic patterns through combining
various individual level characteristics, indicators, and risk factors that may be associated
with SMM can contribute to the identification of high priority areas that need robust
maternal health services.
Research Questions and Hypotheses
The central research question guiding this study was: Are there differences in
SMM rates among geographic location and racial/ethnic (i.e., non-Hispanic Black,
Hispanic, Asian or Pacific Islander, and Native American or Alaska Native) women?
RQ1: Are there geographic variations of SMM across the state of Michigan?
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H01: There are no statistically significant geographic variations in the
incidence of severe maternal morbidity across the state of Michigan.
HA1: There are statistically significant geographic variations in the
incidence of severe maternal morbidity across the state of Michigan by
race and ethnicity.
RQ2: Are there racial and ethnic variations of SMM across the state of Michigan?
H02: There are no statistically significant racial and ethnic variations in the
incidence of SMM across the state of Michigan.
HA2: There are statistically significant racial and ethnic in the incidence of
SMM across the state of Michigan by race and ethnicity.
RQ3: Are there racial/ethnic variation between women who have a health chronic
condition and SMM across the state of Michigan?
H03: There are no statistically significant variations in the prevalence of
a health condition that complicates pregnancy outcomes (i.e., preexisting
diabetes, preexisting hypertension, obesity, mental health diagnosis,
alcohol use during pregnancy, drug use during pregnancy, tobacco use
during pregnancy, gestational diabetes, and gestational hypertension)
across the state of Michigan by race and ethnicity.
HA3: There are statistical significance in the prevalence of a health
condition that complicates pregnancy outcomes (i.e., preexisting diabetes,
preexisting hypertension, obesity, mental health diagnosis, alcohol use
during pregnancy, drug use during pregnancy, tobacco use during
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pregnancy, gestational diabetes, and gestational hypertension) across the
state of Michigan by race and ethnicity.
Theoretical Foundation
For the theoretical framework of this study, I used the social-ecological model,
developed in the 1980s by Urie Bronfenbrenner and the critical race theory developed by
a group of researchers including Kimberle Crenshaw, Neil Gotanda, Gary Peller, Kendall
Thomas, and Derrick Bell’s critical race theory and Arline Geronimus. The socialecological model introduced human development in the context of an entire ecological
system (Bronfenbrenner, 1994). The socio-ecological model suggests that birth outcomes
are impacted by the environment into which a child is born and is subsequently
influenced by the community and society (Bronfenbrenner, 1994). Maternal and infant
health has been studied in the context of the socio-ecological model to provide potential
solutions for healthcare disparities. Additionally, the critical race theory conveyed how
racism contributed to cultural perceptions and societal norms, as well as how that was
represented in the criminal justice system, housing and employment opportunities, and
how policies were enacted (Bell, 1995; Gotanda & Peller, 1995)
Socioecological Model
The ecological model posits that a public health program, such as one designed to
address SMM, is the result of influences across all levels of the problem (Glanz, Rimer,
& Viswanath, 2015). The two specific concepts demonstrated in this model are that
individual behaviors are affected by the social environment and that the behaviors are
molded to multiple levels of influence, including the microsystem, mesosystem,
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exosystem, and macrosystem (Bronfenbrenner, 1994). These terms are more simply
understood when expressed at the individual, interpersonal, organizational, community,
and societal levels; the different levels represent a unique influence on the individual.
Each individual has a unique experience situated within the insidious influences from
policies and laws in addition to the different contexts between and within the levels of
influence. An examination of these dynamic levels can provide more information on the
lived experiences of women. This model can provide consideration for the broader
environmental context where, when, and how childbearing women experience SMM. To
do so requires acknowledgement of an individual’s family values, church, school, lived
experiences and peer influences (i.e., microsystem); the community’s ambulatory health
caresettings, hospitals, and social service offices (i.e., mesosystem); the society’s cultural
values and norms (i.e., exosystemic); and historical events, such as slavery, segregation,
and the attitudes and ideologies of the culture in power (i.e., macrosystemic). In
summary, there are multiple, upstream contributing factors at the microsystem,
mesosystem, exosystem, and macrosystem levels that must be considered in order to
better understand an individual’s health outcomes, and for the purposes of this study,
specifically that of SMM.
Critical Race Theory
In this research, I took into account the work of Kimberle Crenshaw, Neil
Gotanda, Gary Peller, Kendall Thomas, and Derrick Bell’s critical race theory and Arline
Geronimus’s theory of weathering (see Bell, 1995; Geronimus, 2001; Gotanda & Peller,
1995). Geronimus (2001) coined the term weathering in Ethnicity & Disease, describing
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how constant stressors from racism contribute to a premature biologic aging process and
poor health outcomes. Weathering is an integral component of the higher SMM rates that
disproportionately affect African American pregnancy-related complications, which is
displayed in the higher mortality rates from chronic conditions that may contribute to
maternal mortality and morbidity (CDC 2017b; Geronimus, 2001). The critical race
theoretical framework examines race and racism to understand how victims of systematic
racism are affected by cultural perceptions of race and how that effects their lived
experiences and world views as well as how that is represented in the United States (Bell,
1995; Gotanda & Peller, 1995). Health outcomes for racial and ethnic women have
shown similar poor outcomes across income and education levels, suggesting that racism
may contribute to the underlying health disparities; racism has created barriers and also
impacted women’s access to quality healthcare (Admon et al., 2018; Alio et al., 2010;
Howland et al., 2019; Tangel, White, Nachamie, & Pick, 2018).
Utilizing critical race theory in this study helped provide a context for
understanding health disparities in maternal morbidity. Bringing awareness to a public
health issue within a health equity framework can make an impact on the complex and
upstream factors. In order to provide and promote a more equitable impact on women and
reduce SMM rates among racial and ethnic women. Incorporating health equity into all
research will emphasize the impact systems have on individuals and start to shift the
narrative away from individual blame and towards larger systemic responsibility that will
improve every pregnant women’s healthcare quality.
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Nature of the Study
My main priority in this study was to document a population-level analysis of
SMM within delivery hospitalizations in Michigan utilizing data from the 2016–2017
Statewide Inpatient Databases (SID). Using an exploratory, retrospective cohort
framework, I demonstrated geographic and racial/ethnic variance in SMM across the state
of Michigan using demographic, procedural, and diagnosis information. In addition, an
examination of health conditions associated with pregnancy complications was
documented using GIS. The use of GIS software displayed where racial and ethnic
women with SMM and health conditions associated with pregnancy complications reside
to document where disparities persist. Overall, the findings of this study elucidate where
women with health conditions have the highest rates of SMM to help inform public
health decisions concerning targeted, condition-specific interventions and prevention
programs.
Secondary Data Types and Sources of Information
The data for this study were retrieved from the Healthcare Cost and Utilization
Project (HCUP) due to it being the largest, longitudinal hospital database in the United
States, which is funded through the Agency for Healthcare Research and Quality
(Healthcare Cost and Utilization Project, 2019). The SID database the largest source of
administrative data with race and ethnicity for pregnant women who deliver in a
community hospital setting. In the data set, I identified women whose delivery occurred
in a Michigan hospital in 2016 and 2017 and excluded deliveries with missing data.
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SMM was the primary outcome for this study, which was identified using the CDC’s
SMM indicators.
The key outcome (i.e., dependent) variable was the SMM indicated by
International Statistical Classification of Disease and Related Health Problems (ICD-10CM) codes. The 21 SMM indicators to identify SMM criteria were outlined by the CDC,
2017b) and are the most common diagnosis codes associated with SMM, including acute
myocardial infarction, aneurysm, acute renal failure, adult respiratory distress syndrome,
amniotic fluid embolism, cardiac arrest/ventricular fibrillation, disseminated intravascular
coagulation, eclampsia, health failure, puerperal cerebrovascular disorders, pulmonary
edema, severe anesthesia complications, sepsis, shock, sickle cell disease with crisis, air
and thrombotic embolism, blood products transfusion, hysterectomy, and temporary
tracheostomy. The independent variables included four health conditions associated with
pregnancy complications. Admon et al. (2017) identified the common health conditions
associated with obstetric morbidity and mortality among women of childbearing age
across socioeconomic predictors of obstetric outcomes. Taking into account these
conditions and current literature reviews, the four health conditions analyzed in this study
were diabetes; hypertension; obesity; and mental health which included alcohol use
during pregnancy, drug use during pregnancy, and tobacco use during pregnancy. Health
conditions codes were located in the SID database within the diagnosis upon hospital
admission column.
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Literature Strategy
I systematically searched the literature in PubMed, SAGE Journals, Google
Scholar, and ProQuest databases. Using vocabulary and terms combining maternal
health, maternal morbidity, health conditions, chronic conditions, and spatial
epidemiology are listed here. The keywords searched were maternal morbidity, maternal
death, maternal mortality, Michigan, spatial epidemiology, geographic information
system (GIS), obstetric chronic conditions, and multiple chronic conditions. Searches
were conducted between January 1, 2019 and November 1, 2019, with a 10-year data
restriction unless a seminal paper was identified.
Literature Review
Historically, maternal mortality has been a traditional sentinel event for
monitoring maternal health; however, maternal morbidity occurs more frequently and
requires a deeper understanding and a more specific analysis (American College of
Obstetricians and Gynecologists, 2015; The Joint Commission, 2015). While maternal
mortality is easier to identify (due to a sentinel event), maternal morbidity is more
complicated because it is less clearly defined due to reporting, coding, and timing (Main
et al., 2016). SMM is a patient safety concern defined as a life-threatening diagnosis or
enduring a life-saving procedure during a delivery hospitalization (Admon et al., 2018;
Callaghan, Creanga, & Kuklina, 2012). Callaghan et al. (2012) estimated that SMM
during delivery and postpartum hospitalizations has increased by 75% and 114%,
respectively, since the time period between 2008–2009. Moreover, maternal morbidity
has been associated with high levels of preventability, which is fundamental for public
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health practitioners (Kilpatrick et al., 2016). The high levels of preventability associated
with maternal morbidity provide an opportunity to identify risk factors to improve the
health of women and create social change and health policies.
The Joint Commission recognized a maternal morbidity when a woman receives 4
or more units of blood and/or an intensive care unit (ICU) admission; however, due to
recent quality improvement efforts at the national level, this may continue to change in
order to continue to have clarity and consistency in data reporting (Leonard, Main, Scott,
Profit, & Carmichael, 2019; Machiyama et al., 2017). Characterizing SMM events by
diagnostic, administrative, and outcome data determine if the morbidity was preventable
or avoidable, which help systems change and prompt quality improvement within
organizations and, in turn, can guide more strategic public health interventions
(Kilpatrick et al., 2016). While there are nuances and complexities to maternal morbidity
diagnosis and surveillance, it can provide insight into severe pregnancy and delivery
complications because it pertains to upstream risk factors, access to quality care, and
racial and ethnic disparities.
SMM has been categorized by some institutions as a near miss for maternal
mortality because without proper identification and treatment, the complications could
result in a maternal death (Main et al., 2016). Tracking SMM is essential for resource
allocation, identification of priorities for researchers and clinicians, and helps create
policies and procedures that improve the quality of a woman’s life; therefore, focusing
research efforts on SMM is an upstream entry point into, ultimately, decreasing the
maternal mortality rates. The analysis and subsequent interventions for women who
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experience SMM are important for preventing disease and injuries as well as improving
healthcare delivery. The CDC (2017b) published 21 SMM indicators based on ICD-10CM that rely on diagnosis codes from administrative data sources. The identification of
SMM in a data set is a combination of diagnostic codes for an outcome of delivery, the
diagnosis-related group delivery codes, and procedure codes for delivery-related
procedures (Kuklina et al., 2008). The most common diagnoses associated with SMM are
blood transfusion, hysterectomy, temporary tracheostomy with and without ventilation,
postpartum hemorrhage (PPH), hypertension, stroke, renal failure, sepsis, pulmonary
distress, cardiac disease, and an ICU stay (CDC, 2017b; Creanga, Bateman, et al., 2014;
Kilpatrick et al., 2016). According to the CDC (2017b), nine SMM indicators have
increased by more than 50% since 2014, including blood transfusion (399%), acute
myocardial infarction or aneurysm (300%), acute renal failure (300%), adult reparatory
distress syndrome (205%), cardiac arrest (175%), shock (173%), ventilation (93%),
sepsis (75%), and hysterectomy (55%).
Severe Maternal Morbidity and Race/Ethnicity
SMM has been documented in the literature as an increasing trend that poses
concern and draws attention to a widening disparity gap. The Institute of Medicine
defined racial and ethnic disparities in obstetric care by the quality of care and health
outcomes between groups who have similar health insurance and access (Smedley, Stith,
& Nelson, 2003). In the United States, racial disparities in obstetric outcomes have been
documented from preterm delivery to life-long debilitating repercussions from
postpartum events, such as hemorrhage, stroke, and hypertensive disorders (Admon et al.,
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2018). This information has been used to demonstrate disproportionate distribution across
racial and ethnic groups, specifically Hispanic, Black, African-American, Native
American or Alaska Native, and Asian Pacific Islanders (Admon et al., 2018; Creanga,
Bateman, et al., 2014; Howell et al., 2017; Leonard, Main, Scott, et al., 2019; Metcalfe et
al., 2018).
Researchers have highlighted the racial disparities in SMM and demonstrated that
non-Hispanic Black women have a 3–4 times higher risk of mortality and a 9 times
higher risk of morbidity than non-Hispanic White women (Admon et al., 2018; Creanga,
Berg, et al., 2014). The U.S. SMM rates for non-Hispanic White women are 139.2 per
100,000, while the SMM rates for non-Hispanic Black women are 231.1 per 100,000
delivery hospitalization (Admon et al., 2018). Admon et al. (2018) estimated that if racial
and ethnic women experienced SMM at the same rate as non-Hispanic White women,
there would be 8,102 fewer SMM cases per year, resulting in a 28% reduction in SMM
cases nationwide.
Grobman et al. (2015) evaluated the differences in severe PPH, peripartum
infection, and severe perineal laceration and found that non-Hispanic White women were
significantly less likely to experience PPH and perineal laceration than non-Hispanic
Black, Hispanic, and Asian women. Bryant et al. (2012) found that Hispanic and
Asian/Pacific Islander have greater risk factors for atonic PPH. Similarly, Leonard, Main,
Scott, et al. (2019) linked birth certificates to delivery discharge records and found that
SMM was highest in non-Hispanic, Black women and lowest in non-Hispanic White
women. Compared with non-Hispanic, White women, non-Hispanic Black women have a
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greater risk of infections, preterm labor, antepartum hemorrhage, and hypertensive
complications (Cabacungan, Ngui, & McGinley, 2012). The prevalence of preexisting
diabetes was highest among American Indian/Alaska Native women, and the highest
rates of gestational diabetes was highest among non-Hispanic Asian women (Deputy,
Kim, Corney, & Bullard, 2018). Moreover, Hispanics, Asian/Pacific Islanders, and
Native Americans had a greater likelihood of infection, PPH, and gestational diabetes
than non-Hispanic White women (Cabacungan et al., 2012).
The racial and ethnic disparities in the prevalence of SMM associated with
preexisting health conditions have been documented in the literature. Women with
preexisting health diseases or those who develop a pregnancy-associated disease have
increased significantly within non-Hispanic Black and Hispanic populations (Admon et
al., 2018; Metcalfe et al., 2018). Racial and ethnic disparities intertwined with a complex
history of chronic health conditions and disease progression demonstrate the disparate
outcomes in SMM rates. Maternal comorbidities, such as obesity, hypertension, and
diabetes, are more frequently identified in racial and ethnic women (Leonard, Main, &
Carmichael, 2019; Leonard, Main, Scott, et al., 2019; Robbins et al., 2018). The increase
in risk factors prior to pregnancy may contribute to the higher rates of SMM, specifically
in racial and ethnic populations that may have previously been marginalized and lacked
trust in the healthcare system. This reflects multiple levels of health disparities rooted in a
complex history of segregation and unfair clinical trials and treatments (Kennedy,
Mathis, & Woods, 2007). One key example was identified by the Institute of Medicine
who reported that racial and ethnic women are less likely to receive medically indicated
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procedures yet receive more procedures overall that have been shown to be less effective
(Smedley et al., 2003). The persistent health disparities may be due to a delay in
treatment due to distrust in the healthcare system from a history of slavery, segregation,
racism, and the lack of cultural competence and compassion by some providers (CorbieSmith, Thomas, & George, 2002). In order to develop a meaningful analysis, health
disparities were attended to in this SMM study.
Severe Maternal Morbidity and Health Conditions
Complications from preexisting health conditions account for one third of all
maternal deaths (Admon et al., 2018). The emergence of pregnancy-related death due to
cardiovascular disease, cardiomyopathy, and other chronic conditions has increased
(Creanga, Bateman, et al., 2014). Similarly, maternal morbidity trends have increased
across the United States, providing more information about women’s health prior to and
during pregnancy (CDC, 2019). A woman’s health before pregnancy can impact the
future health of mother and child. Admon et al. (2017) found that rates of women with a
chronic condition delivering in a hospital have increased from 66.9 per 1,000 delivery (in
2005–2006) to 91.8 per 1,000 (in 2013–2014).
The CDC (2017a) reported that nearly half of women are overweight or obese
before pregnancy, which has been associated with delivery complications and severe
morbidity. The rate of obesity and diabetes have been greatest in Black women, and those
rates have been on the rise for the past decade for Hispanic women (CDC, 2017a).
Creanga, Bateman, et al.(2014) found that the presence of chronic heart disease, chronic
renal disease, and chronic liver disease was associated with higher rates of severe
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morbidity and that the presence of HIV/AIDS infection doubled the rates of severe
morbidity. Deputy et al. (2018) found that diabetes prevalence increased an infant’s risk
of congenital anomalies and still birth. Diabetes can have serious and long-term effects
on overall health, and elevated blood sugar has been associated with severe
complications, including perinatal loss, preeclampsia, and macrosomia (American
Diabetes Association, 2019). Metcalf et al. (2018) established that that maternal mortality
review committees report that women who have died during pregnancy had one or more
poorly managed health conditions. Overall, SMM among women with chronic health
conditions, specifically multiple chronic health conditions, were significantly higher than
women without chronic conditions (Admon et al., 2017; Admon et al., 2018). It is
important to note that some of the previously mentioned health conditions, such as
obesity and heart disease, are preventable (CDC, 2017b).
The SMM classifications have mainly focused on physical health outcomes;
however, trauma from an obstetric emergency and poor mental health management can
contribute to poor short- and long-term pregnancy outcomes. According to the Michigan
PRAMS (2017), half of the women in Michigan reported feeling depressed before,
during, or after their pregnancy. Among women, depression and anxiety are the leading
pregnancy-related mental health conditions (Creanga, Berg, et al., 2014; Robbins et al.,
2018). Women living with depression are more likely to have a chronic medical condition
and have an increased risk of substance abuse, domestic violence, and poor long-term
health, impacting the mother and infant’s overall health (Chang, Tabet, Elder, Kiel, &
Flick, 2016; Robbins et al., 2018). This is the most underreported aspect of SMM because

23
often times the morbidity occurs outside of the hospital walls (Main et al., 2016). Furuta,
Sandall, and Bick (2012) found that women who experienced severe preeclampsia had a
greater risk of posttraumatic stress disorder. Women living in areas with greater rates of
violence are more likely to experience depression or anxiety, which disproportionally
affects African American, Hispanic, and Native American women (Chang et al., 2016;
Somer et al., 2017). Trauma and mental health are disease burdens that impact women
and family’s mental health before, during, and after pregnancy (Chang, Tabet, Elder,
Kiel, & Flick, 2016; Creanga, Berg, et al., 2014; Robbins et al., 2018).
Severe Maternal Morbidity and Geographic Location
Individual’s health experiences can operate differently in different places (Ballas,
Clarke, Franklin, & Newing, 2017). Health geographers have documented that health
inequalities are a combination of individual characteristics and contextual effects, such as
where an individual grew up and lived (MacQuillan, Curtis, Baker, & Paul, 2019;
Detres, Lucio, & Vitucci, 2014). GIS can help define a study population by spatial
variation in disease risk. Using geospatial maps to analyze spatial health patterns and the
social determinants of risk to identify health related clusters can help distribute health
care resources. GIS allows public health practitioners the opportunity to ascertain where
characteristic of contextual effects contribute to disease or poor health outcomes.
Geographic location is a contributing factor to how and where women receive
services. Rural living leaves women with little to no choice where they receive services
and large metropolitan areas can lack availability and accessibility. The ability to
interpret geographic location, as it relates to healthcare availability and resources, is
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limited. Using data visualization techniques provides neighborhoods, regional
collaborative, policymakers, and clinicians with an evidence base for important public
health programs and funding. Similar analysis have been conducted for income
variations, deprivation, and social demographics to help assess coverage and the breadth
of services in specific geographic locations, which can facilitate targeting public health
services. GIS mapping is an imperative tool for researchers, public health practitioners,
and policymakers that should be readily available to combat this public health crisis and
improve health equity while eliminating health disparities.
Geographic location has been documented as a predictor of overall health
including access to quality care. Different population densities have been associated with
an array of complex geographic challenges (Ballas, Clarke, Franklin, & Newing, 2017).
For example, fewer than 50% of rural women have access to perinatal care within 30
minutes to their home, which continues to worsen due to the closing of more than 100
rural hospitals since 2010 (Centers for Medicare and Medicaid Services [CMS], 2019).
These closures disproportionately affected low-income communities and racial and ethnic
women living in resource poor areas; maternal deaths are more common in rural
communities worldwide (Makanga, Schuurman, von Dadelszen, & Firoz (2016). The lack
of accessible prenatal care contributes to the burden of disease and the high rates of
maternal morbidity and mortality.
Women living in rural areas have higher rates of eclampsia, obstetric embolism,
and uterine rupture (Lisonkova et al., 2016). In response to the rural health burden, the
Centers for Medicare & Medicaid (2019) published an Issue Brief prioritizing health
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policy for rural maternal healthcare. Rurality may contribute to inadequate access to
services, higher rates of poverty and social isolation, which may impact a woman’s
experience during the perinatal periods. Women living in rural areas are more likely to
experience domestic violence and substance use disorders (Bhandari et al, 2015).
Similarly, Admon et al. (2017) found an increasing prevalence of chronic conditions and
substance use disorders for women living in rural communities compared to those within
an urban residence. These rural challenges persist in Michigan, where more than half of
the zip codes have an urban designation (Ratcliffe, Burd, Holder, & Fields, 2016). These
issues present a unique opportunity to demonstrate the need for GIS maps indicating
where disparities persist. Maternity care providers in rural areas must be aware of the
increased burden of disease and how this distresses rural Michigan women.
GIS is most widely used as a visualization tool to explore inequalities of health
care outcomes and is a powerful tool for identification of health care facilities and access
to quality care. The understanding of geographical aspects of health and health care
resources are imperative for health care provisions and location planning and decision
support for allocation of services (Ballas et al., 2017). This detailed information equips
professionals with the knowledge to integrate additional healthcare services to an area
with health inequities. Utilizing GIS to evaluate health and health care from a
geographical perspective will play a major role in evaluating Statewide healthcare policy.
Definitions
Disparities: reference a health outcome that disproportionately affects the racial
and ethnic women (CDC, 2017).

26
Maternal Morbidity: is an overarching term that refers to any event that directly
relates to pregnancy and childbirth or may be a result of sequalae from the unintended
event (Mosley, Koblinsky, Reed, National Research Council, & Committee on
Population, 2000).
Maternal Mortality: is the death of a woman while pregnant or within a year of
the end of pregnancy from any cause (CDC, 2019).
Near miss: is an event that may have resulted in harm to a patient, but the event
did not reach the patient partially due to timely interventions (American College of
Obstetricians and Gynecologists, 2015).
Preexisting Health Conditions: are the nine-health condition associated with
obstetric complications including: preexisting diabetes, preexisting hypertension, obesity,
mental health diagnosis, alcohol us during pregnancy, drug use during pregnancy,
tobacco use during pregnancy, gestational diabetes, and gestational hypertension.
Racial and ethnic women: include non-Hispanic Black, Hispanic, Asian or Pacific
Islander, and Native American or Alaska Native (CDC, 2017).
Severe Maternal Morbidity: is the unexpected outcomes of labor and delivery that
result in significant consequences to a woman’s health defined by 21 indicators and is
described in a rate per 10,000 delivery hospitalizations (CDC, 2017b).
Sociodemographic: refers to the economic, geographic and social measures of an
individual’s experience (CDC, 2017).
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Social Determinants of Health Inequalities: is used to describe the environmental
and societal conditions where individuals are born, live, age, work, grow and can drive
health outcomes (Marmont, 2005).
Spatial Epidemiology: is the field of health geography that focuses on the spatial
distribution of health outcomes (Ostfeld, Glass & Keesing, 2005).
Assumptions
This study should be interpreted with the assumptions and nature of the data set
and study design. First, there is a possibility that each hospital discharge record might not
be unique, and that one woman could have delivered twice during the study period due to
the de-identified data (Admon et al., 2018). Second, health conditions may contribute to
complications during birth and may result in severe maternal morbidity, however, this
may not be the case due to misdiagnosis or a lack of adequate code and could be
associated with low specificity. Third, the claims-based dataset may not always generate
a specific payment for a chronic condition, which may be associated with low sensitivity.
Scope and Delimitations
Each year more than 200 million women become pregnant and many women
experience the burden of severe maternal morbidity, which suggests this maternal health
issue is not a marginal issue. This study takes cross-sectional data, aggregates women
into a cohort and performs an analysis that may underestimate the true SMM rates and
decrease the external validity. The burden of SMM may pose a greater threat than
previously indicated due to undocumented diagnosis, long term sequala of infection, and
may under-reported calculations (Graham et al., 2016; Machiyama et al., 2017). The
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CDC published 21 SMM diagnosis codes, however this is not inclusive of all morbid
events. Main et al. (2016) recommends the inclusion of the CDC’s criteria, as well as
including a prolonged postpartum length of stay, maternal ICU admission, and/or an
administration of any blood product would be a more sufficient measure. Lazariu,
Nguyen, McNutt, Jeffrey, & Kacica (2017) proposed expanding the CDC measure of
severe maternal morbidity to include additional comorbidities and found 3% increase in
the number of cases when compared with the CDC measure only. American College of
Obstetricians and Gynecologist & Society for Maternal Fetal Medicine (2018)
recommend including transfusion of four or more units of blood and an admission into an
ICU where there has been a higher positive predictive value for identifying SMM.
Expanding on the CDC’s measures may provide a more sensitive estimate of the disease
burden and provide clarity to the severity of this public health problem. Finally, the lack
of a concise definition among systems and organizations implies that adopting an existing
screening criterion or creating a document that represents SMM is what most institutions
must do in order to identify gaps in care for quality improvement (American College of
Obstetricians and Gynecologist & Society for Maternal Fetal Medicine, 2018).
Ultimately, the primary and secondary aims of this exploratory study are the description
of health disparities across the state of Michigan. This study may be generalizable to the
public due to the large sample size and may help foster more tailored interventions based
on preexisting health needs.
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Significance
The increasing rates of SMM, which disproportionately affect racial and ethnic
women, demand a call to action. The data visualization techniques proposed will
determine locations where clusters of women experience SMM. Mapping SMM rates and
health conditions by race and ethnicity will indicate where higher rates of adverse
outcomes occur in Michigan, providing a more granular perspective of the specific needs
in those communities. Delivery complications and morbidity identification may provide
indicators of quality of care and racial and ethnic disparities that would benefit from an
upstream public health intervention. This analysis will help determine areas that would
benefit from more robust public health initiatives and interventions. The opportunity to
employ SMM analysis to depict where enhanced public health outreach could have the
highest impact on women’s overall health and well-being is a significant driver for social
change.
Severe Maternal Morbidity as a Public Health Concern
SMM is a public health problem affecting an estimate of more than 700 women
per year and non-Hispanic Black women and American Indian/Alaska Native women
experience the highest rates (42.8 and 32.5, respectively) (Peterson et a., 2019).
Unexpected outcomes of labor and delivery affect women of color at 3.3 and 2.5 times
higher for non-Hispanic Black, and American Indian/Alaska native, respectively, as the
non-Hispanic White women rate (13.0) (Callaghan et al.,2012; Peterson et al., 2019).
Racial and ethnic monitories suffer more complications, injuries and disabilities than
their White counterpart, which are mostly preventable and often lead to poor maternal
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and infant health outcomes. Overall, the burden of SMM disproportionately affects
women of color, living with lower socioeconomic status, chronic conditions, and
dwelling in rural areas (Admon et al., 2017; Leonard et al., 2019). This increasing trend
coupled with unexpected outcomes during labor and delivery can have short- and longterm effects on a woman’s health (CDC, 2017b).
SMM is a public health concern that has been demonstrated among racial and
ethnic women, chronic disease, rurality, and low socioeconomic status disparities. The
disparities in SMM rates demonstrates a call to action for a deeper analysis. Utilizing
spatial epidemiology to map the widening disparities affecting the childbearing
population will better equip public health professionals’ interventions in appropriate zip
codes. Public health agencies, clinicians, and nurses interact with women during the
prenatal stage throughout the pregnancy and into the postpartum periods. Those
interactions occur throughout a variety of clinical and public health services in
ambulatory care settings, inpatient and outpatient settings, community programs, public
health-funded programs, and home visiting programs. Services provided are usually
within the zip code the woman resides, yet many clinicians and health care providers are
unfamiliar or do not live within similar neighborhoods or zip codes. Thus, these health
professionals may not be accustomed to the community characteristics, nuances,
prominent social determinants of health that affect a woman and her perinatal health care
needs (Suplee, Bloch, Hillier, & Herbert, 2018).
The rise in community-engagement action initiatives in the public health arena
has provided an opportunity for clinicians, public health and nursing to learn more about
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the social environments and communities where families reside. GIS has gained
momentum for enhancing data visualization that can be used to better understand zip
code variations and neighborhood characteristics as it relates to the residents’ health.
Mapping data can organize and easily depict community characteristics to inform
clinicians of barriers and challenges the individuals they serve experience. In this study,
public and clinical health care providers can focus on the high rates of health conditions
and rates of SMM for ethnic women and how that relates to their service areas.
Severe Maternal Morbidity and Geographic Information Systems (GIS)
GIS is a spatial software tool that displays geographic data at a neighborhood,
street, census or zip code level. GIS technology helps capture, analyze and visualize
health related data. The commonly used GIS software called ArcGIS is used for creating
maps openly on a web application to share geographic information. GIS has been used in
public health fields to map disease, health care utilization, and aids in identification of
community needs (Detres, Lucio, & Vitucci, 2014). Moreover, on January 12, 2015, the
United States Agency for International Development met in Washington, DC to discuss
global Maternal and Child Survival Programs. This meeting convened 25 global health
organizations, government agencies, donors, and universities advocated for more
equitable analysis for those living in rural and hard to reach populations. The
recommendations placed a strong emphasis on the application of GIS for maternal and
neonatal health data in an effort to reduce preventable maternal and newborn mortality
(Molla et al., 2017). Molla et al. (2017) explained that the data visualization and
geospatial analysis can address key challenges in poorly resourced areas. Not only can
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geospatial analysis be helpful at a global level, but it can help communities identify
health related areas including socio-demographic characteristics, health behaviors, health
outcomes, and factors influence health (Detres, Lucio, & Vitucci, 2014). The use of maps
can engage a wide array of stakeholders from community members to hospital systems
and garner support in discussions about programs that affect an individual’s health
outcomes.
Stopka, Krawczyk, Gradziel, & Geraghty (2014) utilized geographic information
systems and cluster analysis to identify locations where Special Supplemental Nutrition
Program for Women, Infants, and Children (WIC) Program services were needed. The
analysis demonstrated statistically significant clusters of WIC-eligible nonparticipants,
which provided a unique approach to determine where public health outreach would help
improve enrollment. MacQuillan, Curtis, Baker, & Paul (2019) identified subgroups of
women with high rates of gestational diabetes mellitus using birth records and geospatial
mapping. Salehi and Ahmadian (2017) mapped women’s access to hospitals, which
provided a robust identification of high priority areas that needed more access to
advanced maternity care. Innovative analysis that yield maps help identify health related
and physical barriers that contribute to maternal morbidities such as the built
environment, racial segregation, and insufficient housing (Bloch & Cordivano, 2016;
Mehra, Boyd, & Ickovics, 2017). The geospatial maps may prompt locations for deeper
qualitative analysis such as focus groups and structured interviews to understand the
nuances of health behaviors in a specific community. Mapping can be a valuable tool in
the synthesis, exchange, and application of community knowledge to stakeholders and
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nontraditional partners such as housing and youth programming (Detres, Lucio, &
Vitucci, 2014). GIS mapping can accelerate innovation related to health programming for
women to prevent complications and SMM. The literature indicates a growing need in
making GIS data available to the community stakeholders to empower them to use data in
a way that would stratify health problems within an ecological context.
The increasing SMM trends have affected the nation’s women, families, and
infants and prompts a call for a more innovative analysis with open access to medical
journals for public health personnel. The increased incidence of SMM, coupled with
clearly demonstrated racial and ethnic disparities, indicates an exploration of where
women are more likely to have a negative health outcome. Due to the disparate reporting
techniques and urban and rural geographical distribution in Michigan, less is known
about precursors to maternal morbidity by regional health disparities. Spatial
epidemiological methods could provide an innovative means by which to quantify severe
maternal morbidity and pregnancy related health conditions by race and ethnicity. In lieu
of the typical numeric tables and graphs, geo-spatial representations of data can provide a
simplified means by which public health concerns and interventions can be understood
and utilized by those in the broader community.
Conclusion
One of the most influential outcomes reflective of a country’s overall health and
well-being is its maternal and child health outcomes, specifically maternal and infant
mortality. The United States is ranked in the bottom quartile for maternal morbidity and
Michigan rates reflect those national trends. This ranking is due in large part to racial and
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ethnic disparities and pre-existing health conditions. While mortality is the most tragic
event, morbidity plays a close second. High rates of maternal morbidity reflect the gaps
in the healthcare system that can be addressed to reduce the chance of mortality taking
place. The causes of maternal morbidity are diverse, including multiple chronic
conditions, demographic, epidemiological, socioeconomic, and system-level factors.
Despite technological advancements these rates persist and have recently increased over
the past decade.
Healthy People 2020 declared the elimination of health disparities, an
improvement in health equity and overall health for all groups (HealthyPeople.gov,
2017). Researchers have established that racial and ethnic health disparities persist and
are associated with living environments, poverty, unemployment, crime, and racial
segregation (Somer et al., 2017). Yet, the identification of specific, demographic,
socioeconomic, environmental and behavioral factors to explain racial and ethnic
disparities as it relates to health outcomes has not demonstrated the type of success that
Healthy People posed 10 years prior. Understanding the scope of social determinants of
health that occur within zip code can better guide the development of feasible and
relevant interventions to reduce rates of health conditions and racial and ethnic health
disparities. The use of spatial epidemiology and geospatial mapping can demonstrate the
areas in Michigan with a higher level of deprivation, which can prompt tailored and
specific geographical interventions, which is outlined in the next section.
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Section 2: Research Design and Data Collection
Introduction
The purpose of this exploratory study was to describe SMM disparities during
delivery hospitalizations in Michigan from 2016–2017. I used an exploratory cohort
design to demonstrate geographic and racial/ethnic variance in SMM across the state of
Michigan using demographic, procedural, and diagnosis information. In addition, I
documented an examination of health conditions associated with pregnancy
complications using GIS. GIS software was used to display where racial and ethnic
women with SMM and health conditions reside to document where disparities persist.
Overall, the findings of this study elucidate where women with health conditions have the
highest rates of SMM to help inform public health decisions concerning targeted,
condition-specific interventions and prevention programs.
Research Design and Rationale
In this exploratory study, I pooled, cross-sectional, 2016–2017 data from the SID
to create a retrospective cohort of delivery hospitalizations in Michigan. The cohort
consisted of women who were admitted into a Michigan hospital between the years
2016–2017. Obstetric deliveries were stratified out of the larger data set and utilized as
the denominator for the analysis. The primary outcome was the number of women who
experienced a SMM event out of all of the delivery hospitalizations in Michigan between
2016–2017. The covariates controlled in the analysis included age, race/ethnicity,
insurance, and geographic dwelling (i.e., location).
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The dependent variable was SMM as it was defined by the CDC. The independent
variables were the health conditions associated with pregnancy complications; diabetes;
hypertension; obesity; and mental health, including alcohol use during pregnancy, drug
use during pregnancy, and tobacco use during pregnancy. I identified these variables
through all ICD-10-CM diagnostic codes in the discharge record (i.e, 1–30) that indicated
conditions complicating the pregnancy, childbirth, and puerperium outlined in the Ochapter codes. The O-chapter includes all codes related to the perinatal period. I chose to
focus on these conditions rather than pregnancy-related conditions to better inform
prevention and upstream interventions for the greatest impact on women and families in
Michigan. Admon et al. (2018) posited that there is a lack of information on the
prevalence of health conditions by socioeconomic predictors, geographic location,
income, and insurance status. The understanding of the prevalence of health conditions
and its association with SMM is essential for healthcare providers, policy makers, and
public health professions to identify populations that would benefit from evidence-based
interventions to reduce the rates of maternal morbidity and the inequitable health
outcomes for racial and ethnic women.
Currently, most analyses conclude with tables and graphics that show which
variables are statically significant. In this study, I took the analysis a step forward and
mapped the significant existing health conditions by race and ethnicity to depict the
communities with the greatest need to inform where targeted interventions and more
resources are needed. For the purposes of this study, the data were used to depict health
outcomes for racial and ethnic women by geographic location. Current research has
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underutilized geospatial epidemiology to display areas of highest need. The practical
application of GIS provides the capacity to identify where there are high priority
communities, significant health disparities, and poorer health outcomes (Salehi &
Ahmadian, 2017). These geographic characteristics helped provide context for the social
determinants of health, including rural or urban dwellings, to provide a fundamental
understanding of the communities with the greatest disparities. Finally, through this
analysis, I provided critical emphasis on racial disparities, which may impact resource
allocation for equitable perinatal healthcare.
Methodology
Population
I performed the retrospective, pooled, cross-sectional analysis on a sample of all
delivery hospitalization discharges in Michigan between 2016-2017 using the HCUP in
the SID. The total number of hospitalizations accounted for in the SID in Michigan for
2016–2017 was over 2.4 million; HCUP (2019) houses the largest nationally
representative sample of hospital discharges in the United States. The SID contains
discharges from 97% of all U.S. community hospital discharges that includes discharges
from specialist facilities (HCUP, 2019). This database contains a set of clinical and
nonclinical information and includes uninsured individuals. Data for each hospitalization
includes diagnostic and procedure codes, patient demographic characteristics, insurance
status, and information pertaining to the individual’s zip code.
The study population included delivery hospitalizations from 2016–2017 in
Michigan. I identified deliveries by ICD-10-CM codes by converting Kuklina et al.’s
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(2008) enhanced method for identifying obstetric deliveries to the updated ICD-10 codes.
The updated list of obstetric deliveries included Z37 Outcome of delivery diagnosis
related group(DRG 767,768,774,775, 795, 797,798, 805, 806, 807, 951), O80 (DRG 998)
encounter for full-term uncomplicated delivery, O82 (DRG 998) encounter for cesarean
delivery without indication, and excluded O00–O08 ICD-10 codes for pregnancy with
abortive outcomes.
Sampling Procedure
Gaining access to the SID required a Data Use Agreement Training Course and
signed HCUP Data Use Agreement before the data were sent. After the completion of the
training course, the SID required me to provide a Statement of Intended Use, which was
sent to the HCUP Central Distributor and reviewed for approval by the AHRQ team.
Upon receiving approval, the SID sent me the requested data, via U.S. Postal Services, on
a CD-ROM, which was transferred into the Statistical Package for the Social Sciences
(SPSS), Version 25 software. SPSS was used to calculate the sample size in order to test
the research questions and hypotheses of the study. All delivery hospitalizations that fit
the inclusion criteria were utilized.
The identification of SMM as the primary outcome helped test the first
hypothesis. SMM events were identified during delivery hospitalizations using an
algorithm developed by the CDC that uses hospital discharge data, diagnosis, and
procedure codes (i.e., ICD-10 Codes). The original list of SMM indicators was developed
utilizing ICD-9 codes; however, the United States transitioned to the 10th Revision of
ICD codes in October 2015 (CDC, 2017b). The CDC, along with their clinical and public
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health partners, took into account prior validated studies to review this new set of
indicators; Main et al. (2016) found that the previous SMM algorithm had 77%
sensitivity, which was then adapted for ICD-10 coding and this set of indicators.
To identify delivery hospitalizations with SMM in 2016–2017, I used the ICD-10
codes. These codes include 21 indicators of SMM that represent serious complications
during the hospital stay, such as eclampsia and health failure, as well as lifesaving
procedures to manage serious health conditions, such as blood transfusions (CDC,
2017b). The ICD-10 codes associated with SMM were indicated in the discharge field in
the data set. A delivery hospitalization was included in the study population if any of the
21 indicators were present on the discharge summary; the complete list of codes is
available in Appendix A. I identified women with a health condition by searching all
ICD-10-CM diagnostic codes associated with pregnancy complications. The list of
preexisting chronic conditions along with the ICD-10 code is publicily available
information available on the ICD webpage.

40
Table 1
Health Conditions ICD 10-CM Codes
Pregnancy Related Health Condition

Type

ICD-10-CM Code

Diabetes

Preexisting diabetes

Codes within O24.3

Gestational diabetes

Codes within O24.410

Preexisting hypertension

Codes within O10 and O11

Gestational hypertension

Codes within O10 and O11

Obesity

Obesity

Codes within O99.210

Mental health diagnoses

Mental health diagnoses

Codes within O99.340

Alcohol use during pregnancy

Codes within O99.310

Drug use during pregnancy

Codes within O99.320

Tobacco use during pregnancy

Codes within O99.330

Hypertension

Imputing the data from the aforementioned analysis into ArcGIS, I analyzed racial
and ethnic women who experienced preexisting health conditions and a SMM event. The
unit of analysis was the patient’s zip code. Location of residence was defined by the
National Center for Health Statistics’ (2017) Classification and Urban Influence Codes
into four categories: large metro, medium metro, small metro, and micropolitan/urban.
The graphical display for the third aim of my study helped fulfill the practical application
of this research and inform policies for social change.
I used these variables to answer the research questions, along with avoiding Type
II errors (probability = β) related to the power of the test. Using G*Power 3 (Version
3.1.9.4), a power analysis was conducted to determine the sample size and strength of the
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power of the significance among the variables. Due to the large sample size (i.e., over 2.4
million records between 2016–2017), the input parameters for the a priori power analysis
were set to an effect size of .80, alpha level of .05, power of .95, odds ratio of 1.2, and a
two-tailed test (see Faul, Erdfelder, Buchner, & Lang, 2013; Field, 2013). G*Power
generates a sample size for the logistic regression analysis that was utilized to address the
research questions. Based on the assumptions listed previously, the desired sample size
was 2,451 cases (see Faul et al., 2013).
Instrumentation and Operationalization of Constructs
I conducted the descriptive statistics, chi-square, and univariate logistic regression
analysis SPSS, Version 25 (see IBM Corp, 2017). The zip code data were analyzed
utilizing GIS to display data geographically. The robust software utilized to depict
epidemiological trends was created by the Environmental Systems Research Institute
(2019), and I used the ArcGIS Desktop: Release 10.7.1 Version. This tool was used to
visualize and analyze spatial relationships by importing and aggregating data. In this
exploratory study, I demonstrated salient variation between geography and depicted
where health disparities occur as well as clusters of highly vulnerable communities
persist. The initial descriptive and inferential statistics helped address the three research
questions. The GIS analysis generated maps that show SMM by racial and ethnic women
who experienced obesity, diabetes, mental health diagnosis, or hypertension.
Data Analysis Plan
I used the cross-sectional SID to extract all delivery hospitalizations during the
study timeframe. The data were pooled into a 2-year time period to increase the sample
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size and precision of the analysis. The sampling strategy included the identification of all
hospital deliveries occurring between 2016–2017 using an adaptation of Kuklina et al.’s
(2008) standard methods. The first step was to identify the cohort of women who had a
SMM outcome, and the second step was to identify women who experienced SMM and
had one or more health chronic conditions associated with pregnancy complications (see
Table 1). The data sets included deliveries occurring among non-Hispanic White,
Hispanic, non-Hispanic Black, Asian or Pacific Island; and Native American women.
Other variables of interest were age, location, race/ethnicity, and insurance.
The categorization of variables was performed utilizing previous literature
reviews. Payment sources were grouped into Medicaid and other. Age was categorized
into three distinct subgroups reflecting the study populations (i.e., younger than 19, 1934, 35 and older). Race was categorized into three groups Black (non-Hispanic Black),
White (non-Hispanic White), and other (Hispanic, Asian or Pacific Islander, and Native
American or Alaska Native). Geographic location was divided into four meaningful
groups that reflect Michigan’s population, which include large metropolitan, small
metropolitan, micropolitan, and not metropolitan or micropolitan (National Center for
Health Statistics, 2017). Any duplicate cases were excluded from the data, only complete
cases were analyzed.
The central research question guiding this study was: Are there differences in
SMM rates among geographic location and racial/ethnic (i.e., non-Hispanic Black,
Hispanic, Asian or Pacific Islander, and Native American or Alaska Native) women?
RQ1: Are there geographic variations of SMM across the state of Michigan?
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H01: There are no statistically significant geographic variations in the
incidence of severe maternal morbidity across the state of Michigan.
HA1: There are statistically significant geographic variations in the
incidence of severe maternal morbidity across the state of Michigan by
race and ethnicity.
RQ2: Are there racial and ethnic variations of SMM across the state of Michigan?
H02: There are no statistically significant racial and ethnic variations in the
incidence of SMM across the state of Michigan.
HA2: There are statistically significant racial and ethnic in the incidence of
SMM across the state of Michigan by race and ethnicity.
RQ3: Are there racial/ethnic variation between women who have a health chronic
condition and SMM across the state of Michigan?
H03: There are no statistically significant variations in the prevalence of
a health condition that complicates pregnancy outcomes (i.e., preexisting
diabetes, preexisting hypertension, obesity, mental health diagnosis,
alcohol use during pregnancy, drug use during pregnancy, tobacco use
during pregnancy, gestational diabetes, and gestational hypertension)
across the state of Michigan by race and ethnicity.
HA3: There are statistical significance in the prevalence of a health
condition that complicates pregnancy outcomes (i.e., preexisting diabetes,
preexisting hypertension, obesity, mental health diagnosis, alcohol use
during pregnancy, drug use during pregnancy, tobacco use during
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pregnancy, gestational diabetes, and gestational hypertension) across the
state of Michigan by race and ethnicity.
Characteristics of the Study Population
The total population of 2016-2017 hospital deliveries from the SID was used to
demonstrate descriptive statistics for deliveries by maternal characteristics age, race,
insurance type, and geographic location, as well as health conditions associated with a
pregnancy complication. The demographics tables show the percent of delivery
hospitalizations for each sociodemographic characteristic of the mother (age, race,
insurance, geographic location), and well as the percent of women in each category
demonstrates the relative number of delivery hospitalizations for each demographic
variable. The characteristics of the population are also detailed by the percent of delivery
hospitalization with a health condition known to complicate pregnancy (diabetes,
hypertension, obesity, and mental health conditions) from 2016-2017. These descriptive
analyses help frame subsequent work for the severe maternal morbidity analysis.
Chi-Square Analysis
In total, 21 indicators were used to demonstrate the incidence of Severe Maternal
Morbidity in the total population of 2016-2017 hospital deliveries. The data were entered
into IBM SPSS Statistics Version 25 and analyzed using chi-square tests (IBM Corp,
2017). Utilizing SPSS and testing each covariate separately, a simple chi-square
contingency table indicated that all sociodemographic variables were significant at the p
= 0.05 level. The sociodemographic variables and the percent of deliveries with SMM, as
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well as the percent of deliveries with a SMM event were used to find statistical
significance.
The second analysis tested whether diabetes, mental health, hypertension or
obesity was significantly significant with a SMM diagnosis, independently. Each health
conditions was analyzed independently with 95% CI. This represents the percent of
deliveries with SMM, according to health conditions of the mother. I tested for
significance at the .05 level to indicate which health conditions indicators were
statistically significant.
Logistic Regression
I analyzed the health conditions and the sociodemographic indicators for an
adjusted odds ratio (OR) associated with severe maternal morbidity, 2016-2017. To
compare women with health conditions, I performed two logistic regression models. The
partial logistic regression model included only sociodemographic variables and the
second full logistic regression model included sociodemographic variables and health
conditions. Both models were tested for an OR with a 95% confidence interval and lower
and upper bounds. The procedure was based on Wald statistics produced significant
variables.
Geospatial Analysis
The final analysis was entered into ArcGIS to demonstrate where racial and ethnic
women who experienced a health condition and an SMM event were located. The unit of
analysis was zip code; each zip code was coded large metro, medium-small metro,
micropolitan/urban. The figures depict women who had any SMM event and a health
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condition that complicated pregnancy to portray the most vulnerable population. The
prevalence of these health conditions associated with obstetric morbidity are diabetes,
hypertension, obesity, and mental health diagnosis. This highlights where women living
with the highest risks and who could benefit from community public health efforts to
ameliorate the deleterious effects of these compound problems.
Threats of Validity
Statewide administrative data is validated before final submission into the HCUP
however, these diagnosis and procedure codes do not provide information on prenatal
care, the severity of a condition or follow-up outside of the hospital setting. The crosssectional nature of the data limits our knowledge of whether the conditions have changed
over time or led to mortality. Moreover, this analysis only accounted for the CDC’s
definition of severe maternal morbidity, which includes 21 indicators that correspond
with ICD-10 codes identified only during the hospitalization of record. The indicators do
not specify length of stay or units of blood transfused during the delivery hospitalization,
which might impact the level of morbidity.
Ethical Procedures
Regarding ethical considerations, the patient’s information was deidentified and
remained confidential. Ethical approval was received from Walden University with the
International Review Board (IRB) Approval Number 01-03-20-0667638.
Summary
The analysis of SMM for maternal demographics and maternal health conditions
demonstrates the distribution for all delivery hospitalizations from 2016-2017 in
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Michigan. The significant predictors of SMM for the maternal characteristics were age,
race, location, and Medicaid insurance. For this analysis, the health conditions associated
with SMM were hypertension, obesity, diabetes, and a mental health diagnosis. The
logistic regression model will demonstrate differences between races, location, insurance,
and health conditions. The GIS analysis depicts SMM rates with either obesity,
hypertension, mental health diagnosis, or diabetes. This analysis will show the
geographic variation of maternal health outcomes across the state of Michigan. Finally,
this contribution will further the knowledge on health inequities to inform public health
professionals residing in those communities to improve preventative programs, health
access, and eliminate health disparities within the results section.
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Section 3: Presentation of the Results and Findings
Introduction
Increasing rates of maternal mortality and morbidity are well documented in the
United States, but there is limited state-specific documentation of disparities. Disparities
in complications from pregnancy-related health conditions are the leading causes of
maternal mortality and morbidity in the United States and similar issues occur in
Michigan (Michigan Maternal Mortality Surveillance Program, 2018). State-level
analysis can identify risk for delivery-related morbidity among women with health
conditions, including those with diabetes, hypertension, mental health diagnosis, and
obesity. The prevalence of those four conditions has increased over time; yet, less is
known about the prevalence of the aforementioned conditions and SMM. It is unclear
whether the prevalence of these conditions are associated with an SMM event and if the
rates have stabilized, decreased, or worsened in recent years. Moreover, it is unclear how
the prevalence of these conditions varies by patient’s location. This information is
necessary for healthcare providers and policy makers to identify populations that would
benefit from evidence-based interventions to reduce maternal morbidity in Michigan.
To address these gaps in knowledge, the objective of this study was to estimate
2016–2017 trends in the prevalence of conditions that may exacerbate SMM among
delivery hospitalizations in Michigan. This included evaluating SMM and women who
have experienced a health condition that may exacerbate her condition during pregnancy.
The health conditions associated with pregnancy include hypertension, diabetes, obesity,
and mental health diagnosis, which are generally undiagnosed (i.e., mental health) or
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mismanaged conditions that contribute to poor obstetric conditions. The purpose of this
analysis was to convey the prevalence of health conditions by geographic location that
have not been comprehensively examined in a statewide sample of delivering women.
Additionally, depicting those disparities by race and ethnicity may help clinicians provide
adequate and culturally competent care to women with 1 of the 4 conditions. The rates of
maternal morbidity and the association with health inequities by race and ethnicity for
women experiencing SMM provided rationale for geospatial analysis to more accurately
pinpoint where disparities exist. The final geospatial mapping depicted the geographic
areas of women experiencing a SMM event and 1 of the 4 health conditions in order to
provide healthcare professionals the information they need to improve maternal health
outcomes.
In this study, I provided analysis of SMM among geographic location, race and
ethnicity, and the four health conditions, using ArcGIS software spatial reference and
analysis to present geographical awareness to this persistent problem. In this study, I
describe (a) SMM in Michigan from 2016–2017, (b) depict the geographic locations
where women experience SMM who present with a health condition affecting pregnancy,
and (c) examine the differences between race and ethnicity and SMM.
The overarching research question was: Are there differences in SMM rates
among geographic location and racial/ethnic (i.e., non-Hispanic black, Hispanic, Asian or
Pacific Islander, and Native American or Alaska Native) women. The specific research
questions addressed in this study were:
RQ1: Are there geographic variations of SMM across the state of Michigan?
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RQ2: Are there racial and ethnic variations of SMM across the state of Michigan?
RQ3: Are there racial/ethnic variations between women who have 1 of the 4
health conditions and SMM across the state of Michigan?
The results section includes the findings and how the secondary data were
collected. In this section, I report on baseline descriptive, demographic characteristics,
population, and univariate analysis. The results also include statistical assumptions,
statistical analysis, findings, and summary. The data are displayed using tables, graphs,
and maps because they are appropriate for the study design.
Data Collection of Secondary Data Set
Using the SID to conduct this analysis, I extracted all delivery hospitalization
discharges in Michigan from 2016–2017, which included 94% of all Michigan hospitals,
and totaling 2,474,118 hospital discharges. The SID is the largest nationally represented
state sample of hospital discharges in the United States. Each hospitalization
encompasses clinical and nonclinical data, including diagnosis and procedure codes,
payment source, patient and hospital location, and patient demographic variables that
include race and ethnicity (HCUP, 2019). I identified 202,514 delivery hospitalizations in
Michigan from 2016–2017. Deliveries were identified using the ICD-10-CM codes
provided by the Michigan Department of Health and Human Services. The data were
cleaned to include delivery hospitalizations with a race/ethnicity indicator; abortion,
abortive outcomes, and any duplicate medical record numbers were excluded from the
dataset.
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In order to construct the SMM data set, I utilized the CDC’s SMM ICD-10 codes,
diagnosis codes (i.e., 1–30), and procedure codes (i.e., 1–15). I identified 2,460 SMM
events between 2016–2017 in the data. Next, the prevalence of diabetes (i.e., preexisting
and gestational); hypertension (i.e., preexisting and gestational); obesity (i.e., a body
mass index >30); and mental health conditions that were associated with pregnancy,
including tobacco, drug, and alcohol use. Each delivery hospitalization was flagged for
one or more of the health condition diagnosis codes. If the delivery hospitalization did
not indicate a SMM with diabetes, hypertension, obesity, or mental health diagnosis, the
case was included into the data set. I focused the analysis on pregnancy-related
conditions rather than preexisting conditions, which were defined using the ICD-10-CM
codes listed in Appendix B.
I controlled for four covariates: age, patient location, Medicaid insurance, and
race/ethnicity. Patient location was defined using the Urban Influence Codes, which
include large metropolitan areas with at least 1 million residents, small metropolitan areas
with less than 1 million residents, micropolitan areas that are distinguished by nonmetro
size and adjacency to other metro areas, and neither metropolitan nor micropolitan.
Payment was grouped into Medicaid and other, which included self-pay, Medicare, and
private; this was pertinent because about half of births are covered by Medicaid in
Michigan (MDHHS, 2018). Race was categorized into three categories: non-Hispanic
White, non-Hispanic Black, and Other, which included Hispanic, Asian or Pacific
Islander, Native American or Other. Cases without race were excluded.
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I used logistic regression models and cross tabulations to obtain estimates of
pregnancy-related health conditions to estimate the rates at which any one delivery
hospitalization had any of the health conditions. Data were pooled into a 2-year period to
increase precision in the analysis. Prevalent conditions were compared with age, race,
patient location, and payer with an adjusted odds ratio associated with SMM. Two
models were used for all subgroups to generate the differences between women
experiencing SMM and women experiencing SMM and a health condition. Two-tailed p
values (p < .001) were considered statically significant using SPSS. The SMM data were
uploaded into the ArcGIS system to map the percentage of the four health conditions and
SMM by zip code as well as race and ethnicity and SMM.
Results
The total number of women delivering in a hospital setting from 2016–2017 was
202,514 unique cases. The cohort consisted of delivery hospitalizations among nonHispanic White (n = 138,937); non-Hispanic Black (n = 39,485); and Hispanic, Asian or
Pacific Islander, Native American or Other (n = 24,092). Medicaid paid for
approximately 41.5% of all deliveries; among non-Hispanic Black deliveries, Medicaid
covered 67.6% (CI 67.1–68.0); among non-Hispanic White 32.8% (CI 32.6–33.1) of
deliveries; and Hispanic, Asian or Pacific Islander, Native American, or Other 48.9% (CI
(48.3–49.6) of deliveries. Women were predominately 19–34 years old between all races,
with the non-Hispanic Black age at 26.49 (CI 26.43–26.55); non-Hispanic White age at
28.86 (CI 28.83–28.89); and Hispanic, Asian or Pacific Islander, Native American, or
Other age at 28.85 (CI 28.78–28.92). Non-Hispanic Black women had the highest rate of
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teen pregnancy (5.0%), and Hispanic, Asian or Pacific Islander, Native American, or
Other had the highest rate of deliveries over the age of 35 years old (17.6%).
Table 2
Sociodemographic Characteristics of Delivery Women by Race and Ethnicity, Michigan,
2016-2017
Characteristics

Non-Hispanic White
N
% (95% CI)

Non-Hispanic Black
N
% (95% CI)

Hispanic, Asian or Pacific Islander,
Native American or Other
N
% (95% CI)

Age

138,937
28.86 (28.83-28.89)

39,485
26.49 (26.43-26.55)

24,092
28.85 (28.78-28.92)

Medicaid

45,627
32.8 (32.6-33.1)

26,671
67.6 (67.1-68.0)

11,790
48.9 (48.3-49.6)

Other

93,300
67.2 (66.9-67.4)

12,810
32.4 (31.2-32.9)

12,301
51.1 (50.4-51.7)

Large metro

53,156
38.3 (38.0-38.5)

26,822
68.0 (67.5-68.5)

12,229
50.8 (50.2-51.4)

Small metro

58,026
41.8 (41.5-42.1)

12,271
31.1 (30.7-31.6)

9,909
41.2 (40.6-41.8)

Micropolitan

58,026
12.8 (12.6-12.95)

270
0.68 (0.61-0.77)

1,465
6.09 (5.8-6.4)

9,939
83
7.16 (7.0-7.3)
0.21 (0.17-0.26)
Note. N = 202,514.Table 3 includes all delivery hospitalizations
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1.94 (1.8-2.1)

Insurance

Geographic location

Neither

The largest number of patient’s reside in a large metro geographic location
(45.5%). The racial and ethnic distribution for large metro area was non-Hispanic White
(57.6%); non-Hispanic Black (29.1%); and Hispanic, Asian or Pacific Islander, Native
American, or Other (13.3%). However, Table 2 indicates the proportion of non-Hispanic
Black women living in large metro areas, such as inner cities, was highest 68% (CI 67.5–
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68.5), whereas the highest proportion of non-Hispanic White women live in small
metropolitan areas (41.8%; CI 41.5–42.1), such as suburbs.
Among all delivery hospitalizations, mental health diagnosis was the most
frequent diagnosis (17.7%), followed by obesity (15.8%), diabetes (8.1%), and
hypertension (3.3%). Compared with deliveries among non-Hispanic White women,
deliveries among non-Hispanic Black and Hispanic, Asian or Pacific Islander, Native
American, or Other had higher prevalence of nearly every health condition examined,
including diabetes, obesity, and hypertension with the exception of a mental health
diagnosis. Proportionally, racial and ethnic women experienced these health conditions
more frequently than their non-Hispanic, White counterparts when comparing within race
(see Table 3).
The highest proportion of women living with diabetes was Hispanic, Asian or
Pacific Islander, Native American, or Other at 12.6% (CI 12.2–13.0). The highest
proportion of women living with obesity was non-Hispanic Black women at 17.9% (CI
17.5–18.3) compared with non-Hispanic White women at 15.3% (CI 15.1–15.4) and
Hispanic, Asian or Pacific Islander, Native American, or Other women at 15.8% (CI
15.4–16.3). Mental health diagnosis was most common in non-Hispanic White women
with 19.7% (CI 19.5-19.9). The highest percentage of diabetes was found in the Hispanic,
Asian or Pacific Islander, Native American, or Other population with 12.6% (CI 12.2–
13.0).
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Table 3
Pregnancy Conditions that Complicate Pregnancy and Race/Ethnicity, Michigan, 20162017
Health Conditions
that Complicate
Pregnancy

Non-Hispanic White
N
% (95% CI)

Non-Hispanic Black
N
% (95% CI)

Hispanic, Asian or Pacific Islander,
Native American or Other
N
% (95% CI)

No

128,192
92.3 (92.1-92.4)

36,785
93.5 (92.9-93.4)

21,060
87.4 (87.0-87.8)

Yes

10,745
7.7 (7.6-7.9)

2,700
6.8 (6.6-7.1)

3,032
12.6 (12.2-13.0)

No

135,252
97.3 (97.3-97.4)

37,036
93.8(93.6-94.0)

23,578
97.9 (97.7-98.0)

Yes

3,685
2.65 (2.6-2.7)

2,449
6.2 (6.0-6.4)

514
2.1 (2.0-2.3)

No

111,561
80.3 (80.1-80.5)

33,150
84.0 (83.6-84.3)

21,869
90.7 (90.4-91.1)

Yes

27,376
19.7 (19.5-19.9)

6,335
16.0 (15.7-16.4)

2,223
9.2 (8.9-9.6)

No

117,740
84.7 (84.6-84.9)

32,416
82.1 (81.7-82.5)

20,275
84.2 (83.7-84.6)

Yes

21,197
15.3 (15.1-15.4)

7,069
17.9 (17.5-18.3)

3,817
15.8 (15.4-16.3)

Diabetes

Hypertension

Mental heealth

Obesity

Note. N = 202,514. All univariate analysis between race and the four health conditions were significant (p < .05)

Severe Maternal Morbidity
In total I identified 2,460 delivery hospitalizations with a SMM indicator,
representing 1.2% of all delivery hospitalizations in Michigan, which is a rate of 121.5
per 10,000 deliveries. The highest number of women with SMM were non-Hispanic
White (n = 1,334), followed by non-Hispanic Black (n = 800) and Hispanic, Asian or
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Pacific Islander, Native American or Other (n = 326), which trended with the overall
proportion of each race/ethnicity. However, the rates varied across race and ethnicity; the
SMM rate for non-Hispanic White was (1%) 100 per 10,000 deliveries, non-Hispanic
Black was (2%) 200 per 10,000 deliveries and Other was (1.4%) 140 per 10,000
deliveries, all were significant p < .05. The sociodemographic model in Table 5 depicts
the SMM and age, location, and race. The patient’s location was the greatest predictor of
SMM (p < .001), followed by race and ethnicity (p < .001).
Medicaid insurance covered about half of the deliveries for women who
experienced an SMM event (49.9%). Although insurance type was statically significant,
women who had Medicaid insurance (OR 1.20, 95% CI:1.1–1.3) had similar odds of
having an SMM event with women who had Medicaid without a health condition (OR
1.23, 95% 1.1-1.3). Non-Hispanic Black women who experienced a SMM had a higher
rate of Medicaid insurance coverage (67.6%), compared to non-Hispanic White women
(32.8%) and Hispanic, Asian or Pacific Islander, Native American, or Other (49%).
Severe Maternal Morbidity, Health Conditions and Race/Ethnicity
For the women who had a SMM event, the percentages of the four health
conditions associated with pregnancy complications were diabetes (10%), obesity (20%),
mental health diagnosis (19.6%), and hypertension (6.3%). In total, across all racial and
ethnic groups, 56% of women with an SMM outcome experienced one or more health
conditions. Table 5 depicts the sociodemographic model with health outcomes where
diabetes was the only health condition not statistically significant with SMM as an
outcome (p = 0.086). Women with hypertension had the highest risk associated with
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SMM (OR 1.56, 95% CI:1.3–1.8), followed by obesity (OR 1.23, 95% CI:1.1–1.4), and
mental health diagnosis (OR 1.19, 95% CI:1.1–1.3). Women with hypertension had the
highest chance of SMM (OR 1.56, 95% CI:1.3–1.8), with non-Hispanic Black women
experiencing hypertension more frequently than non-Hispanic White and Hispanic, Asian
or Pacific Islander, Native American, or Other. Women with at least one health condition
were anywhere from 1.20—1.50 (95% CI:1.1–1.8) times likely to experience SMM
compared to women without these conditions.
Table 4
Adjusted Odds Ratio (OR) associated with severe maternal morbidity in Michigan, 20162017
Sociodemographic Model

Sociodemographic Model with Health
Conditions

Age at Delivery

ChiSquare

OR

LB

UB

ChiSquare

OR

LB

UB

19-34 years vs under 18
years

0.07

0.82

0.66

1.01

0.03

0.78

0.63

0.97

Over 35 years vs under 18
years

0.32

1.13

0.89

1.43

0.87

1.02

0.80

1.29

Over 35 years vs 19-34
years

<.0001*

1.38

1.24

1.53

<.0001*

1.30

1.17

1.45

Large metro vs small metro

<.0001*

1.81

1.65

1.99

<.0001*

1.84

1.67

2.02

Large metro vs
micropolitan

<.0001*

1.42

1.21

1.67

<.0001*

1.43

1.22

1.68

Small metro vs
micropolitan

0.0049*

0.78

0.67

0.93

0.0004*

0.78

0.67

0.92

<.0001*

1.23

1.12

1.34

<.0001*

1.20

1.09

1.30

<.0001*

1.78

1.62

1.97

<.0001*

1.76

1.59

1.94

Patient Location

Payment
Medicaid vs other (private,
medicare, self-pay)
Race
Non-Hispanic Black vs
non-Hispanic White
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Hispanic, Asian or Pacific
Islander, Native American
or Other vs non-Hispanic
White

<.0001*

1.31

1.15

1.48

<.0001*

1.34

1.78

1.51

Hispanic, Asian or Pacific
Islander, Native American
or Other vs non-Hispanic
Black

<.0001*

0.73

0.64

0.84

<.0001*

0.75

0.67

0.87

Diabetes (Yes vs No)

0.09

1.13

0.98

1.29

Obesity (Yes vs No)

<.0001*

1.23

1.11

1.36

Mental Health/ Substance
use (Yes vs No)

<.0008*

1.19

1.08

1.32

Hypertension (Yes vs No)

<.0001*

1.55

1.31

1.85

Chronic conditions Associated with Pregnancy

Note. N = 202,514. Stastical significance was demonstrated by * (p < .05)

Severe Maternal Morbidity, Health Conditions, and Geographic Location
Spatial distribution of risk factors for maternal ill-health (SMM) were modeled by
adverse maternal health conditions indicated as independent variables. The use of
geographic methods for modeling the effect of risk factors on SMM was minimal;
logistic regression portrayed geographic location as the greatest predictor of SMM and
GIS was utilized as a means to describe the analysis. The statistical modeling assumes
that the statistical associations were affected by geography. These results portray the
number, percent, and density of SMM with health conditions across Michigan. Counts
and percentages were categorized by natural breaks and quartiles, respectively. Results
provided three sets of maps; each analysis was depicted by the zip code where the patient
lived or where the patient indicated during their hospital stay.
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The SMM 2016-2017 map depicts the number of SMM during the time period
2016-2017. The highest number of SMM cases occurred in three different zip codes in
Southeast Michigan, which had 33-45 SMM cases between 2016-2017. The zip codes
with the highest SMM were Pontiac (33), Taylor (39), Dearborn (37), and the highest in
Detroit (45). The areas with the lowest SMM rates were in rural parts of Michigan, likely
due to population density. The highest number of disease diagnosis for the four health
conditions were as follows; SMM and diabetes was Dearborn, Inkster, Belleville; SMM
and hypertension was Detroit and Saginaw; SMM and obesity was Detroit; SMM and
mental health diagnosis was Lapeer, Saginaw, Lansing, Pontiac, Warren, Taylor, Wayne,
Ypsilanti, and Jackson. The second set of maps was a collection of three maps depicting
SMM by the percent of race/ethnicity groups per zip code. The third set portrays the
percent of each health condition associated with SMM per zip code.
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Figure 1. Severe maternal morbidity in Michigan from 2016-2017.
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Figure 2. Percent of severe maternal morbidity for hispanic, asian or pacific islander,
native american, or other in Michigan 2016-2017.

62

Figure 3. Percent of severe maternal morbidity for non-hispanic Black in Michigan 20162017.
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Figure 4. Percent of severe maternal morbidity for non-hispanic White in Michigan
2016-2017.
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Figure 5. Percent of mental health diagnosis with severe maternal morbidity in Michigan
2016-2017.
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Figure 6. Percent of obesity diagnosis with severe maternal morbidity, 2016-2017.
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Figure 7. Percent of hypertension diagnosis with severe maternal morbidity, 2016-2017.
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Figure 8. Percent of diabetes diagnosis with severe maternal morbidity, 2016-2017.
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Summary
The full logistic regression model indicated that geographic location was the
greatest predictor of SMM and health conditions associated with pregnancy complication.
The second greatest predictor was race, followed by hypertension diagnosis, age,
insurance (payer), obesity, and mental health diagnosis. For the first study hypothesis, I
rejected the null hypothesis that there are no differences in severe maternal morbidity
rates among geographic location and racial/ethnic (non-Hispanic Black, Hispanic, Asian
or Pacific Islander, and Native American, or Alaska Native) women. I rejected the null
hypothesis that there are no geographic variations of severe maternal morbidity across the
state of Michigan. I rejected the null hypothesis that there are no racial and ethnic
variations of severe maternal morbidity across the state of Michigan. I rejected the null
hypothesis that there are no racial/ethnic variation between women who have experience
hypertension, obesity or mental health diagnosis. Finally, I failed to reject the null
hypothesis that there are no racial/ethnic variation between women who have a diabetes
diagnosis and SMM outcome.
We found that the average SMM rate for Michigan residents was (1.2%) 121.5
per 10,000 deliveries. However, the rates varied across race and ethnicity with the nonHispanic Black population having the highest rate of SMM (200 per 10,000 deliveries).
In order to better understand these associations, specifically geographic location
variation, I used data visualization techniques. I used spatial analysis to determine the
location of areas where women had a health condition and experienced SMM during their
delivery hospitalization. The set of maps that depicts the percent of health conditions with
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an SMM outcome to accurately inform which disease interventions would help women in
a specific zip code.
The third set of maps demonstrated the four health conditions by zip code that
were most prevalent during the SMM events. For example, the highest number of obesity
diagnosis and SMM were located in Detroit. However, the highest percentage of obesity
occurred in more rural and small metro locations such as Sault Saint Marine, Pickford,
Kinross, Hawks, Atlanta, Alger, Gladwin, Hastings, Holland, Decatur, Coloma, Minden
City, Elkton, and more; that is where 100% of the cases were obese on admission.
Similarly, the highest number of diabetes diagnosis was in Dearborn, Inkster, Belleville,
but the highest percentage of diabetes was located in small metros or rural locations like
Dewitt, Alanson, Bad Axe, Casco, Dundee, and more.
These findings present a review of delivery hospitalizations in Michigan from
2016-2017, severe maternal morbidity as an outcome, and four health conditions
associated with pregnancy complications that may exacerbate the chances of an SMM
event. Secondly, the racial and ethnic variation in disease outcome, as well as the
variation in health conditions across the State, was identified. The geographical variation
in both health conditions and racial and ethnic diversity was depicted via GIS
technologies. Evaluating geographic patterns in the association between four health
conditions and SMM introduced more detailed descriptions of where women are
experiencing poor health outcomes. Although geographical representation remains on the
periphery of many maternal health analysis, these results demonstrate need for
visualization techniques for the association between geographic location and SMM to
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pinpoint areas of greatest need that inform public health professionals to make social
changes, which is outlined in the following section.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
SMM is an ongoing problem that affects more than 50,000 women annually
(Callaghan et al., 2012). There is a public health need to improve reproductive health
services with the intent to improve health equity while increasing the number of healthy
pregnancies and deliveries. In a response to this public health issue, during the past
decade, reducing poor maternal health outcomes has been a leading priority with the U.S.
Department of Health and Human Services, declaring the reduction of pregnancy-related
complications and illness a Healthy People 2020 objective (HealthyPeople, 2017).
However, there is still work to be done. The physical and psychological ailments that
directly and indirectly affect women’s health contribute to a myriad of consequences,
including ill-health, loss of workdays, inability to bond with baby, sleeplessness, and
trauma (Mazul et al., 2017). Since SMM occurs 100 times more frequently than maternal
mortality (Admon et al., 2017), SMM surveillance is impactful for monitoring maternal
outcomes while providing population-level context and geographical differences for
public health interventions.
Defining methods for identifying SMM at the population-level utilizing ICD-10CM diagnosis and procedure codes for delivery hospitalizations to describe trends and
health disparities will help states inform maternal morbidity interventions. While there
are maternal health impacts, there are challenges navigating the correct diagnosis and
procedure codes as well as trying to understand the diverse data systems to examine the
patterns and risk factors to implement upstream interventions (Conrey et al., 2019). There
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is limited published information that establishes how states are tracking SMM, what data
they are using, and the subsequent policy and interventions based on the findings. The
purpose of this study was to describe SMM in Michigan, depict where SMM and health
conditions related to pregnancy complications occur, and address the infrastructure to
improve health equity while focusing on efforts to reduce maternal morbidity.
Interpretation of the Findings
I used spatial epidemiology to advance the assessment of risk factors for SMM,
obesity, hypertension, mental health diagnosis, and diabetes. These health conditions,
described in the literature as risk factors that fall within social determinants of risk, were
examined as characteristics in a complex pathway leading to poor maternal health
outcomes. However, the differences in SMM rates are complex, and researchers have
examined patient characteristics, systems, healthcare professional, and facility because
they contribute to obstetrical care (Hirshberg & Srinivas, 2017). Access to adequate
perinatal care aiding in prevention against maternal morbidities and mortalities has been
found as a protective factor; yet, researchers have identified barriers and challenges to
preconception, prenatal, and postpartum care due to unplanned pregnancies, competing
priorities, and limited time in the clinic setting, respectively (Khan, Boyle, Lang, &
Harrison, 2019; Mazul, Ward, & Ngui, 2017). The findings of this study added to that
current knowledge while identifying geographic disparities in Michigan as well as
pinpointing specific gaps for disease-specific interventions.
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Socioecological Model, Critical Race Theory, and Severe Maternal Morbidity
Each SMM is unique and poses its own set of risk factors, systemic barriers, and
health outcomes for each individual. Each woman lives within a complex socioecological
framework, where each interaction with public policy, their community, the organizations
they frequent and interact within, as well as their social networks and individual
experiences impact their daily lives. Generational trauma and exposure to chronic stress
has shaped the socioecological system women are born into and grow accustom to.
Different lived experiences contribute to how an individual may access preconception,
perinatal, and postpartum health services as well as the number of interactions with the
healthcare system (Cabacungan, Ngui, & McGinley, 2012). This may be due to monetary
resources, implicit or explicit bias from providers, geographic location, or insurance type
(Khan, Boyle, Lang, & Harrison, 2019). It is important to note that the individual
differences in health status, as well as healthcare access, should be taken into
consideration when analyzing data based on health outcomes on the basis that healthcare
access, insurance, and availability is not equal across the state; moreover, racial and
ethnic disparities persist across the Michigan for SMM rates.
Analyzing health data is only one step towards providing intervention
recommendations and rationale for resources and funding, so it is critical to include a
historical context for more accurate findings and subsequent recommendations. Sharing
these racial and ethnic disparities while framing this analysis around the socioecological
theory alone was inadequate. It was vital to introduce the critical race theory due to an
U.S. history of White privilege, where White individuals have been protected by the
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government, financial institutions, policy forces, and have been prioritized for safety and
resources. The racial and ethnic health disparities, perpetuated by structural barriers, are
still heavily documented in the literature; college-educated, Black women are 3 times
more likely to experience maternal complications than White women without a high
school education, and women living in geographically underserved areas present with
more health conditions (New York City Department of Health and Mental Hygiene,
2016). The structural barriers persist for racial and ethnic women and contribute to higher
rates of poor health. Bohren et al. (2015) found that mistreatment of women during
childbirth in a healthcare setting contributes to morbidity and mortality. Therefore, the
multifaceted interactions of a history of racial inequities and individual and
environmental networks contribute to health outcomes, and when coupled with
intergenerational trauma, women’s lives are completely altered.
The exposure to chronic stress and lack of trust in the healthcare system is now
understood be to a reason why marginalized ethnic women have greater rates of poor
health outcomes and other chronic illnesses compared to non-Hispanic White women
(McKinnon et al., 2016). This has been an ongoing public health issue for more than 40
years; from 1979 to 2010, Black women had a twofold higher rate of chronic
hypertension than White women (Ananth et al., 2019). Not only do health conditions
contribute to ill-health, but unfair treatment by the society at large has led to detrimental
effects on pregnancy outcomes, often leading to SMM or sequalae of an adverse risk
during delivery (Williams, Priest, & Anderson, 2016). Greater attention to understanding
risks and resources in the social environment that are linked to geographic location;
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race/ethnicity; and how that accumulation of innate, environmental, and acquired factors
across the life course perpetuates or remedies health outcomes to influence SMM rates is
necessary in making a social change.
Health Conditions
In addition to the racial and ethnic disparities, many women who have chronic,
mismanaged, or underdiagnosed health conditions experiences higher rates of SMM
(Creanga, Syverson, Seed & Callaghan, 2017). Providing targeted interventions for
women experiencing these conditions is especially important, but the interventions are
often inadequately delivered. The prevalence of diabetes among women during
reproductive years has increased, disproportionately affecting racial and ethnic women
further perpetuating poor health outcomes (Bardenheier et al., 2015; Deputy et al., 2018).
When these health conditions are diagnosed before pregnancy, healthcare providers can
counsel on interventions that may postpone, delay, treat, or manage any additional harm
to the mother and infant. However, when these health conditions are not established
before conception or during the perinatal period, severe maternal and infant
complications can occur. In fact, only about half of postpartum women with existing
diabetes report receiving preconception care (Kim, Deputy, & Robbins, 2018). Treating
women with respect and dignity by managing health conditions associated with
pregnancy complications is one way to interpret these findings and create social impact.
Lastly, the mental health diagnosis and increased contribution of behavioral
health conditions linked to cases of SMM has been identified as an emerging concern.
The findings of this study reveal higher prevalence of mental health diagnosis for non-
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Hispanic White women. However, underreporting for racial and ethnic women may
contribute to a disparity in screening and referral to treatment. The possibility of racial
and ethnic women receiving less adequate care by way of underdiagnosed and
understudied mental health conditions requires a deeper analysis across healthcare
services. Universal screening and referral to evidence-based treatment may benefit
women and remedy a systematic barrier. Similarly, other health conditions may showcase
system-level disparities for current screening and referral practices.
In this study, I quantified the magnitude of racial and ethnic disparities as well as
geographic location and the prevalence of SMM among women who deliver in Michigan.
My two main interpretations of this data are: (a) racial and ethnic inequities persist and
(b) there is a relationship between geography and health conditions. Identifying the areas
where healthcare services are needed is imperative for the fair and just distribution of
these services. Healthcare systems can provide powerful resources, such as preventative
initiatives to reduce the burden of disease. Shifting the responsibility to healthcare
systems, instead of individual responsibility, by equipping health systems with
surveillance and effective monitoring, such as GIS, will help identify the needs of
vulnerable communities to address individual needs and systematic problems.
Limitations of the Study
Statewide administrative data are validated before final submission into the
HCUP; however, these diagnosis and procedure codes do not provide information on
prenatal care, the severity of a condition, or follow-up outside of the hospital setting; the
cross-sectional nature of the data limits the knowledge of whether the conditions have
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changed over time, between racial groups, or led to a mortality. Administrative databases
that lack patient characteristics, such as age and body mass index, may lack necessary
information (Grobman et al., 2015).
The data lack some socioeconomic fields, smoking status, primary language, and
other demographics that may contribute to inadequate health care services and potentially
SMM (Metcalfe et al., 2018). It is also possible that an increased SMM rate may reflect
rigorous coding practices over time (Admon et al., 2017). Moreover, I only accounted for
the CDC’s definition of SMM, which includes 18 indicators that correspond with ICD-10
codes identified only during the hospitalization of record, in this study.
I examined four of the health conditions associated with pregnancy complications
and did not do a full analysis of all health-related complications. There are other leading
diagnosis-based indicators of SMM that include adult respiratory distress syndrome and
acute renal failure (CDC, 2018; New York City Department of Health and Mental
Hygiene, 2016). Finally, this study lacks information regarding preconception obstetric
care received that has benefits to reduce maternal morbidity and poor health outcomes.
The findings should be interpreted considering the limitations of the data source, study
design, and geographic visualization methodology. Expanding inclusive maternity care
management programs that integrate preconception health through the first year
postpartum, particularly among racial and ethnic women with a prior health conditions,
are mechanisms to reduce SMM.
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Recommendations
In this study, geographic location was the greatest predictor of SMM with race
and ethnicity being a close second. This geographic and racial SMM analysis presented
opportunities to examine these disparities more closely. Poor health conditions contribute
to the health disparities across Michigan, and the number of racial and ethnic women
living with a health condition is higher when compared with their White counterparts. I
recommend a deeper analysis into the four health conditions related to pregnancy
outcomes examined in this study (i.e., mental health diagnosis, diabetes, obesity, and
hypertension) and the relationship with sociodemographic factors, such as poverty,
neighborhood resources, and social support. While there is evidence of increased focus
on describing patterns of maternal morbidity, the collective impact of morbidity and the
extent to which it effects women is poorly understood. The varying effects SMM has on
women can be exacerbated by the environment and conditions in which they live; living
with poverty, racial inequalities, multiple health conditions, and inadequate resources
during pregnancy compound and can result in poor mental health and a litany of other
physical diagnoses. The physical and psychological function of a woman experiencing a
SMM event may dissipate after childbirth; however, the sequelae of poor birth
experiences in addition to health conditions, fatigue, pain, depression, anxiety, and restful
sleep may continue to impact a woman’s day-to-day functioning and disproportionately
effect racial and ethnic women.
The nuances prompt another layer of exploration. In addition to other analysis,
collecting qualitative data to examine the lived experiences and world views of women
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and families impacted by SMM could provide more information into the overall trends
and why certain zip codes experience disparities. The daily structural and social barriers
women face can be detrimental to their health and can contribute to poor pregnancy
outcomes. Conducting a mixed methods approach to SMM could help elucidate the social
determinants of disease and potentially identify modifiable risk factors that contribute to
one area more than another.
Each health condition is uniquely complex in relationship to pregnancy, thus a
deeper analysis into the interplay between health conditions, sociodemographic risk
factors, and SMM may provide richer results. Each of the four health conditions present
vastly different upstream interventions effecting women differently depending on where
they live and the resources easily available to them, especially mental health,
hypertension, and diabetes diagnosis. These health conditions have more granular
information that may provide more definitive results. This is due, in part, to the mental
health diagnosis including alcohol, tobacco and substance use during pregnancy, while
hypertension and diabetes include preexisting and gestational diagnosis. Moreover, these
health conditions, coupled with a history of unfair treatment, effect racial and ethnic
groups disproportionately and, as a result, have led to disparate health outcomes. Thus, it
is our recommendation that each health condition associated with pregnancy
complications be studied in its relationship to severe maternal morbidity and what that
means for women living in geographically diverse areas. Finally, an exploration on cost
savings pertaining to the different health conditions and SMM interventions may provide
useful. Comparing intervention costs, health care costs, childcare costs, and the societal
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costs including lost workdays, long-term rehabilitation, and mental health services may
provide reason to explore more upstream interventions. Estimating cost savings could
help resources and policy interventions to create sustainable social change for all effected
by SMM.
Implication for Professional Practice and Social Change
The higher rates of SMM for non-Hispanic Black, Hispanic, Asian or Pacific
Islander, Native American, and/or Other races and ethnicities have been the subject of
considerable attention. The persistent gaps in risk between non-Hispanic White women
and other races and ethnicities has plagued the public health realm. Yet, the inequities
continue. In the February 2020 issue of Obstetrics and Gynecology, Dr. William M
Callaghan states,
“Health and medical care exist in the context of the larger society, and our failure
to address the needs of women and the inequities borne by marginalized
populations is a reflection of reconciling what we say we value and what we do to
achieve our valued goals (Callaghan, 2020).”
Addressing the SMM problem with changes to the professional field, first by focusing on
health equity and systems change, is the only acceptable way to tackle this public health
problem. The changes in practice will require social change within organizations, clinical
practices, local health departments, schools, governmental bodies and anywhere women
seek services, treatment, and support.
There are three main implications resulting from the findings. The first is that
among all four health conditions explored, three of those conditions emerged as
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important risk factors associated with SMM. Second, the results support an emphasis on
preconception health and access to pregnancy services that aligns with statewide and
national strategies. Finally, these implications shared with stakeholders in Michigan may
help prioritize strategies to prevent the increased maternal morbidity rates.
Professional Practice
This analysis prompts a call to action for those striving to improve access to
healthcare services prior to delivery for women living in Michigan. It is evident that
adverse pregnancy and health outcomes persist among racial and ethnic health women
who live in large metropolitan zip codes. These findings suggest interventions based on
the patient’s location may prove an innovative way to tailor resources for specific
healthcare needs. For example, focusing efforts on reducing SMM geographically has
been shown to be effective for women living in in resource-poor areas (Suplee, Bloch,
Hillier, & Herbert, 2018).
For professionals working with women and children, providing GIS maps of
SMM with information regarding the health conditions that complicate pregnancy may
help providers engage with community organizations to modify interventions for the
greatest needs. Enhanced surveillance of SMM can help identify preventability and
outline actionable recommendations to mitigate poor maternal health outcomes and
optimize maternal health service delivery. Sharing population-level data with public
health and clinical health providers will improve their understanding of factors that
contribute to health disparities. Understanding the zip codes where women return, after a
delivery hospitalization, and the related patterns of health in those areas, as well as
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recurring health outcomes can impact perinatal health care interventions to tailor specific
needs.
GIS maps assist in targeted implementation interventions that impact women to
positively impact her health throughout her life course. This includes contraception
access and family planning services, preconception health that helps manage health
conditions, and providing accessible perinatal care and education across the state
(Robbins et al., 2018). Importantly, enrolling women in insurance programs before they
become pregnant and ensuring that women and infants have insurance until one year after
birth may impact SMM rates (Ranji, Gomez, & Salganicoff, 2019). Finally, providing
wrap around services by creating relationship with women prior to pregnancy, assisting
her while pregnant, and supporting her in the recovery after childbirth and during the
postpartum period is an opportunity to reduce health disparities and feelings of fear of the
healthcare system. Providing long-term care for women prior to pregnancy, throughout
pregnancy and postpartum would remedy the social barriers of geographic isolation,
problematic health conditions, and offer hope for lasting social change in the maternal
healthcare delivery system.
Social Impact
Geospatial analysis has grown in popularity to advance precision public health
initiatives. Precision public health focuses on the use of technologies (such as GIS) to
deliver the correct intervention at the right time to the right population (Khoury,
Iademarco, & Riley, 2016). This would guide public health practice to individually
tailored interventions and policies that may benefit the public with more precise
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interventions and medicine. Moreover, this approach leads to social change and disease
treatment because it takes into consideration the individual variability, environment and
lifestyle.
The data demonstrates that specific zip codes and neighborhoods have higher
rates of SMM than others and clinical, public health, and policy interventions can be
directed to those areas. The findings of this study support the need for enhanced
screening and timely treatment for racial and ethnic women. While the graphs in the
results do not demonstrate the exact location of disease, they pinpoint areas with greater
risk. Taking into consideration precision public health, these maps may be a helpful tool
in beginning the alignment of resources for the greatest need. Moreover, GIS allows local
government to consider policy changes to be considered for lasting social change. By
utilizing precision public health, localities can provide context for additional efforts
among populations with limited resources, greater risk of a health condition, and have the
greatest social impact. Professional practice can have a great deal of impact on social
well-being. When a woman seeks care from a professional, they trust the professional
will pose the least amount of harm on them. Identifying opportunities to change deeply
rooted professional practices will ultimately create a compound of social change
benefiting women and their families. When professionals advocate for women and their
health, families, and societies benefit for a more harmonious lived experience.
Conclusion
Increases in maternal mortality rates over recent years has prompted more
national attention on women’s health. Maternal morbidity is a continuum of short-term
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adverse effects to long-term life-altering events and are 100 times more common than
maternal mortality. However, defining maternal morbidity as the unintended outcomes of
pregnancy that results in a significant short or long-term consequence to a women’s
health may overlook some of the environmental, societal, or delayed onsets of SMM. The
prevalence of death remains low overall, however maternal death only showcase the
more obvious aspects of healthcare delievery with respect to the number of pregnancies
and pregnancy complications. Complications due to health conditions and maternal
mental health have not been examined as closely, leading many to explore risk factors,
health disparities, and access to quality healthcare in SMM. This research is an important
step in understanding the precursors to morbidity and the remaining, less obvious, 90% of
healthcare delivery.
SMM was identified at significantly higher frequency across racial and ethnic
women, which are consistent with findings identified in Admon et al. (2017) nationwide
analysis. The data suggests that racial and ethnic women have a significant proportion of
obstetric complications, many of which are preventable, and improved quality of
healthcare interventions are a considerable key factor in the prevention of maternal
morbidity. The implementation of precision public health interventions for health
condition management, as well as hospital centric interventions including the Alliance for
Innovation safety bundles and racial and ethnic disparities bundles are actionable steps
that can be taken to reduce disparities in poor obstetric outcomes. Disparities will not be
eliminated by improved public health interventions or hospital safety bundles alone.
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Implicit bias trainings, cultural sensitivity and health literacy trainings are also needed to
create social change in healthcare environments.
In summary, we found racial and ethnic disparities in overall severe maternal
morbidity among non-Hispanic Black, Hispanic, Asian or Pacific Islander, and Native
American compared with non-Hispanic White women. The prevalence of health
conditions associated with SMM varied geographically and provided insight into
identifying opportunities for public health interventions. It is clear that within zip codes
and between zip codes there are health inequalities in morbidity rates. Whether those
differences in morbidity rates are related to access to quality healthcare, hospital services,
or perinatal care is unclear. However, within the broader health context, there continues
to be a debate around the relationship between health and place, as well as the bases of
health inequities (Ballas et al., 2017). Health is qualified at an individual level, but
healthcare issues are geographical in nature. Individual health is determined by a
multitude of predisposing factors, but also personal geographic. Where an individual was
raised, where they live, work, play, and all of which affect health outcomes, ill-health and
access to healthcare, as well as the quality of treatment available.
In closing, exposure to environmental factors are spatially clustered but behaviors
are also inherently linked to geographic locations such as zip codes. Health behaviors,
access to quality care, social environmental, and stressors tend to spatially cluster
effecting individuals similarly in specific areas. There is a clear correlation between
geographic ill-health and health needs. Tools to identify health conditions by underlying
demographic and indicators have been identified. I have identified GIS as an important
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tool for visualizing health disparities and evaluating areas where improved interventions
are necessary. Thus, I must strive for deeper analysis, and consistent levels of care
relative to geographic need in order to protect and promote women’s health for
generations to come.
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Appendix A: Center for Disease Control and Preventions Severe Maternal Morbidity
Indicators
Center for Disease Control and Preventions Severe Maternal Morbidity Indicators
(ICD-10-CM)
DIAGNOSI ICD-10
Descriptions
S
1. Acute myocardial infarction
I21.01

ST elevation (STEMI) myocardial infarction
involving left main coronary artery
I21.02
ST elevation (STEMI) myocardial infarction
involving left anterior descending coronary artery
I21.09
ST elevation (STEMI) myocardial infarction
involving other coronary artery of anterior wall
I21.11
ST elevation (STEMI) myocardial infarction
involving right coronary artery
I21.19
ST elevation (STEMI) myocardial infarction
involving other coronary artery of inferior wall
I21.21
ST elevation (STEMI) myocardial infarction
involving left circumflex coronary artery
I21.29
ST elevation (STEMI) myocardial infarction
involving other sites
I21.3
ST elevation (STEMI) myocardial infarction of
unspecified site
I21.4
Non-ST elevation (NSTEMI) myocardial
infarction
I21.9
Acute myocardial infarction, unspecified
I21.A1
Myocardial infarction type 2
I21.A9
Other myocardial infarction type
I22.0
Subsequent ST elevation (STEMI) myocardial
infarction of anterior wall
I22.1
Subsequent ST elevation (STEMI) myocardial
infarction of inferior wall
I22.2
Subsequent non-ST elevation (NSTEMI)
myocardial infarction
I22.8
Subsequent ST elevation (STEMI) myocardial
infarction of other sites
I22.9
Subsequent ST elevation (STEMI) myocardial
infarction of unspecified site
2. Acute Renal Failure diagnosis

104
N17.0
Acute kidney failure with tubular necrosis
N17.1
Acute kidney failure with acute cortical necrosis
N17.2
Acute kidney failure with medullary necrosis
N17.8
Other acute kidney failure
N17.9
Acute kidney failure, unspecified
O90.4
Postpartum acute kidney failure
3. Adult Respiratory Distress Syndrome diagnosis
J80
J95.1

Acute respiratory distress syndrome
Acute pulmonary insufficiency following thoracic
surgery
J95.2
Acute pulmonary insufficiency following
nonthoracic surgery
J95.3
Chronic pulmonary insufficiency following
surgery
J95.821
Acute postprocedural respiratory failure
J95.822
Acute and chronic postprocedural respiratory
failure
J96.00
Acute respiratory failure unspecified whether with
hypoxia or hypercapnia
J96.01
Acute respiratory failure with hypoxia
J96.02
Acute respiratory failure with hypercapnia
J96.20
Acute and chronic respiratory failure unspecified
whether with hypoxia or hypercapnia
J96.21
Acute and chronic respiratory failure with hypoxia
J96.22
Acute and chronic respiratory failure with
hypercapnia
R09.2
Respiratory arrest
4. Amniotic fluid embolism
O88.111
O88.112
O88.113
O88.119
O88.12
O88.13
5. Aneurysm

Amniotic fluid embolism in first trimester
Amniotic fluid embolism in second rimester
Amniotic fluid embolism in third trimester
Amniotic fluid embolism in pregnancy
Amniotic fluid embolism in childbirth
Amniotic fluid embolism in puerperium

I71.00
I71.01
I71.02

Dissection of unspecified site of aorta
Dissection of thoracic aorta
Dissection of abdominal aorta
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I71.03
I71.1
I71.2
I71.3
I71.4
I71.5
I71.6

Dissection of thoracoabdominal aorta
Thoracic aortic aneurysm, ruptured
Thoracic aortic aneurysm, without rupture
Abdominal aortic aneurysm, ruptured
Abdominal aortic aneurysm, without rupture
Thoracoabdominal aortic aneurysm, ruptured
Thoracoabdominal aortic aneurysm, without
rupture
I71.8
Aortic aneurysm of unspecified site, ruptured
I71.9
Aortic aneurysm of unspecified site, without
rupture
I79.0
Aneurysm of aorta in diseases classified elsewhere
6. Cardiac arrest/ventricular fibrillation
I49.01
Ventricular fibrillation
I49.02
Ventricular flutter
I46.2
Cardiac arrest due to underlying cardiac condition
I46.8
Cardiac arrest due to other underlying condition
I46.9
Cardiac arrest, cause unspecified
7. Disseminated Intravascular Coagulation
D65
D68.8
D68.9
O72.3
8. Eclampsia
O15.00

Disseminated intravascular coagulation
[defibrination syndrome]
Other specified coagulation defects
Coagulation defect, unspecified
Postpartum coagulation defects

Eclampsia complicating pregnancy, unspecified
trimester
O15.02
Eclampsia in pregnancy, second trimester
O15.03
Eclampsia in pregnancy, third trimester
O15.1
Eclampsia in labor
O15.2
Eclampsia in the puerperium
O15.9
Eclampsia, unspecified as to time period
9. Heart failure/arrest during procedure or surgery
I97.120
I97.121
I97.130

Postprocedural cardiac arrest following cardiac
surgery
Postprocedural cardiac arrest following other
surgery
Postprocedural heart failure following cardiac
surgery
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I97.131

Postprocedural heart failure following other
surgery
10. Internal injuries of thorax, abdomen, and pelvis
Not carried forward (either very low frequency or imprecise usage)
11. Intracranial injuries
Not carried forward (either very low frequency or imprecise usage)
12. Puerperal Cerebrovascular Disorder
I60.00
I60.01
I60.02
I60.10
I60.11
I60.12
I60.2
I60.20
I60.21
I60.22
I60.30
I60.31
I60.32
I60.4
I60.50
I60.51

Nontraumatic subarachnoid hemorrhage from
unspecified carotid siphon and bifurcation
Nontraumatic subarachnoid hemorrhage from
right carotid siphon and bifurcation
Nontraumatic subarachnoid hemorrhage from left
carotid siphon and bifurcation
Nontraumatic subarachnoid hemorrhage from
unspecified middle cerebral artery
Nontraumatic subarachnoid hemorrhage from
right middle cerebral artery
Nontraumatic subarachnoid hemorrhage from left
middle cerebral artery
Nontraumatic subarachnoid hemorrhage from
anterior communicating artery
Nontraumatic subarachnoid hemorrhage from
unspecified anterior communicating artery
Nontraumatic subarachnoid hemorrhage from
right anterior communicating artery
Nontraumatic subarachnoid hemorrhage from left
anterior communicating artery
Nontraumatic subarachnoid hemorrhage from
unspecified posterior communicating artery
Nontraumatic subarachnoid hemorrhage from
right posterior communicating artery
Nontraumatic subarachnoid hemorrhage from left
posterior communicating artery
Nontraumatic subarachnoid hemorrhage from
basilar artery
Nontraumatic subarachnoid hemorrhage from
unspecified vertebral artery
Nontraumatic subarachnoid hemorrhage from
right vertebral artery
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I60.52
I60.6
I60.7
I60.8
I60.9
I61.0
I61.1
I61.2
I61.3
I61.4
I61.5
I61.6
I61.8
I61.9
I62.00
I62.01
I62.02
I62.03
I62.1
I62.9
I63.00
I63.011
I63.012
I63.013
I63.019

Nontraumatic subarachnoid hemorrhage from left
vertebral artery
Nontraumatic subarachnoid hemorrhage from
other intracranial arteries
Nontraumatic subarachnoid hemorrhage from
unspecified intracranial artery
Other nontraumatic subarachnoid hemorrhage
Nontraumatic subarachnoid hemorrhage,
unspecified
Nontraumatic intracerebral hemorrhage in
hemisphere, subcortical
Nontraumatic intracerebral hemorrhage in
hemisphere, cortical
Nontraumatic intracerebral hemorrhage in
hemisphere, unspecified
Nontraumatic intracerebral hemorrhage in brain
stem
Nontraumatic intracerebral hemorrhage in
cerebellum
Nontraumatic intracerebral hemorrhage,
intraventricular
Nontraumatic intracerebral hemorrhage, multiple
localized
Other nontraumatic intracerebral hemorrhage
Nontraumatic intracerebral hemorrhage,
unspecified
Nontraumatic subdural hemorrhage, unspecified
Nontraumatic acute subdural hemorrhage
Nontraumatic subacute subdural hemorrhage
Nontraumatic chronic subdural hemorrhage
Nontraumatic extradural hemorrhage
Nontraumatic intracranial hemorrhage,
unspecified
Cerebral infarction due to thrombosis of
unspecified precerebral artery
Cerebral infarction due to thrombosis of right
vertebral artery
Cerebral infarction due to thrombosis of left
vertebral artery
Cerebral infarction due to thrombosis of bilateral
vertebral arteries
Cerebral infarction due to thrombosis of
unspecified vertebral artery
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I63.02
I63.031
I63.032
I63.033
I63.039
I63.09
I63.10
I63.111
I63.112
I63.113
I63.119
I63.12
I63.131
I63.132
I63.133
I63.139
I63.19
I63.20
I63.211
I63.212
I63.213
I63.219

Cerebral infarction due to thrombosis of basilar
artery
Cerebral infarction due to thrombosis of right
carotid artery
Cerebral infarction due to thrombosis of left
carotid artery
Cerebral infarction due to thrombosis of bilateral
carotid arteries
Cerebral infarction due to thrombosis of
unspecified carotid artery
Cerebral infarction due to thrombosis of other
precerebral artery
Cerebral infarction due to embolism of
unspecified precerebral artery
Cerebral infarction due to embolism of right
vertebral artery
Cerebral infarction due to embolism of left
vertebral artery
Cerebral infarction due to embolism of bilateral
vertebral arteries
Cerebral infarction due to embolism of
unspecified vertebral artery
Cerebral infarction due to embolism of basilar
artery
Cerebral infarction due to embolism of right
carotid artery
Cerebral infarction due to embolism of left carotid
artery
Cerebral infarction due to embolism of bilateral
carotid arteries
Cerebral infarction due to embolism of
unspecified carotid artery
Cerebral infarction due to embolism of other
precerebral artery
Cerebral infarction due to unspecified occlusion or
stenosis of unspecified precerebral arteries
Cerebral infarction due to unspecified occlusion or
stenosis of right vertebral arteries
Cerebral infarction due to unspecified occlusion or
stenosis of left vertebral arteries
Cerebral infarction due to unspecified occlusion or
stenosis of bilateral vertebral arteries
Cerebral infarction due to unspecified occlusion or
stenosis of unspecified vertebral arteries
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I63.22
I63.231
I63.232
I63.233
I63.239
I63.29
I63.30
I63.311
I63.312
I63.313
I63.319
I63.321
I63.322
I63.323
I63.329
I63.331
I63.332
I63.333
I63.339
I63.341
I63.342
I63.343

Cerebral infarction due to unspecified occlusion or
stenosis of basilar arteries
Cerebral infarction due to unspecified occlusion or
stenosis of right carotid arteries
Cerebral infarction due to unspecified occlusion or
stenosis of left carotid arteries
Cerebral infarction due to unspecified occlusion or
stenosis of bilateral carotid arteries
Cerebral infarction due to unspecified occlusion or
stenosis of unspecified carotid arteries
Cerebral infarction due to unspecified occlusion or
stenosis of other precerebral arteries
Cerebral infarction due to thrombosis of
unspecified cerebral artery
Cerebral infarction due to thrombosis of right
middle cerebral artery
Cerebral infarction due to thrombosis of left
middle cerebral artery
Cerebral infarction due to thrombosis of bilateral
middle cerebral arteries
Cerebral infarction due to thrombosis of
unspecified middle cerebral artery
Cerebral infarction due to thrombosis of right
anterior cerebral artery
Cerebral infarction due to thrombosis of left
anterior cerebral artery
Cerebral infarction due to thrombosis of bilateral
anterior arteries
Cerebral infarction due to thrombosis of
unspecified anterior cerebral artery
Cerebral infarction due to thrombosis of right
posterior cerebral artery
Cerebral infarction due to thrombosis of left
posterior cerebral artery
Cerebral infarction to thrombosis of bilateral
posterior arteries
Cerebral infarction due to thrombosis of
unspecified posterior cerebral artery
Cerebral infarction due to thrombosis of right
cerebellar artery
Cerebral infarction due to thrombosis of left
cerebellar artery
Cerebral infarction to thrombosis of bilateral
cerebellar arteries
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I63.349
I63.39
I63.40
I63.411
I63.412
I63.413
I63.419
I63.421
I63.422
I63.423
I63.429
I63.431
I63.432
I63.433
I63.439
I63.441
I63.442
I63.443
I63.449
I63.49
I63.50
I63.511

Cerebral infarction due to thrombosis of
unspecified cerebellar artery
Cerebral infarction due to thrombosis of other
cerebral artery
Cerebral infarction due to embolism of
unspecified cerebral artery
Cerebral infarction due to embolism of right
middle cerebral artery
Cerebral infarction due to embolism of left middle
cerebral artery
Cerebral infarction due to embolism of bilateral
middle cerebral arteries
Cerebral infarction due to embolism of
unspecified middle cerebral artery
Cerebral infarction due to embolism of right
anterior cerebral artery
Cerebral infarction due to embolism of left
anterior cerebral artery
Cerebral infarction due to embolism of bilateral
anterior cerebral arteries
Cerebral infarction due to embolism of
unspecified anterior cerebral artery
Cerebral infarction due to embolism of right
posterior cerebral artery
Cerebral infarction due to embolism of left
posterior cerebral artery
Cerebral infarction due to embolism of bilateral
posterior cerebral arteries
Cerebral infarction due to embolism of
unspecified posterior cerebral artery
Cerebral infarction due to embolism of right
cerebellar artery
Cerebral infarction due to embolism of left
cerebellar artery
Cerebral infarction due to embolism of bilateral
cerebellar arteries
Cerebral infarction due to embolism of
unspecified cerebellar artery
Cerebral infarction due to embolism of other
cerebral artery
Cerebral infarction due to unspecified occlusion or
stenosis of unspecified cerebral artery
Cerebral infarction due to unspecified occlusion or
stenosis of right middle cerebral artery
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I63.512
I63.513
I63.519
I63.521
I63.522
I63.523
I63.529
I63.531
I63.532
I63.533
I63.539
I63.541
I63.542
I63.543
I63.549
I63.59
I63.6
I63.8
I63.81
I63.89
I63.9
I65.01
I65.02
I65.03

Cerebral infarction due to unspecified occlusion or
stenosis of left middle cerebral artery
Cerebral infarction due to unspecified occlusion or
stenosis of bilateral middle arteries
Cerebral infarction due to unspecified occlusion or
stenosis of unspecified middle cerebral art
Cerebral infarction due to unspecified occlusion or
stenosis of right anterior cerebral artery
Cerebral infarction due to unspecified occlusion or
stenosis of left anterior cerebral artery
Cerebral infarction due to unspecified occlusion or
stenosis of bilateral anterior arteries
Cerebral infarction due to unspecified occlusion or
stenosis of unspecified anterior cerebral a
Cerebral infarction due to unspecified occlusion or
stenosis of right posterior cerebral artery
Cerebral infarction due to unspecified occlusion or
stenosis of left posterior cerebral artery
Cerebral infarction due to unspecified occlusion or
stenosis of bilateral posterior arteries
Cerebral infarction due to unspecified occlusion or
stenosis of unspecified posterior cerebral
Cerebral infarction due to unspecified occlusion or
stenosis of right cerebellar artery
Cerebral infarction due to unspecified occlusion or
stenosis of left cerebellar artery
Cerebral infarction due to unspecified occlusion or
stenosis of bilateral cerebellar arteries
Cerebral infarction due to unspecified occlusion or
stenosis of unspecified cerebellar artery
Cerebral infarction due to unspecified occlusion or
stenosis of other cerebral artery
Cerebral infarction due to cerebral venous
thrombosis, nonpyogenic
Other cerebral infarction
Other cerebral infarction due to occlusion or
stenosis of small artery
Other cerebral infarction
Cerebral infarction, unspecified
Occlusion and stenosis of right vertebral artery
Occlusion and stenosis of left vertebral artery
Occlusion and stenosis of bilateral vertebral
arteries
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I65.09
I65.1
I65.21
I65.22
I65.23
I65.29
I65.8
I65.9
I66.01
I66.02
I66.03
I66.09
I66.11
I66.12
I66.13
I66.19
I66.21
I66.22
I66.23
I66.29
I66.3
I66.8
I66.9
I67.0
I67.1
I67.2

Occlusion and stenosis of unspecified vertebral
artery
Occlusion and stenosis of basilar artery
Occlusion and stenosis of right carotid artery
Occlusion and stenosis of left carotid artery
Occlusion and stenosis of bilateral carotid arteries
Occlusion and stenosis of unspecified carotid
artery
Occlusion and stenosis of other precerebral
arteries
Occlusion and stenosis of unspecified precerebral
artery
Occlusion and stenosis of right middle cerebral
artery
Occlusion and stenosis of left middle cerebral
artery
Occlusion and stenosis of bilateral middle cerebral
arteries
Occlusion and stenosis of unspecified middle
cerebral artery
Occlusion and stenosis of right anterior cerebral
artery
Occlusion and stenosis of left anterior cerebral
artery
Occlusion and stenosis of bilateral anterior
cerebral arteries
Occlusion and stenosis of unspecified anterior
cerebral artery
Occlusion and stenosis of right posterior cerebral
artery
Occlusion and stenosis of left posterior cerebral
artery
Occlusion and stenosis of bilateral posterior
cerebral arteries
Occlusion and stenosis of unspecified posterior
cerebral artery
Occlusion and stenosis of cerebellar arteries
Occlusion and stenosis of other cerebral arteries
Occlusion and stenosis of unspecified cerebral
artery
Dissection of cerebral arteries, nonruptured
Cerebral aneurysm, nonruptured
Cerebral atherosclerosis
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I67.3
I67.4
I67.5
I67.6

Progressive vascular leukoencephalopathy
Hypertensive encephalopathy
Moyamoya disease
Nonpyogenic thrombosis of intracranial venous
system
I67.7
Cerebral arteritis, not elsewhere classified
I67.81
Acute cerebrovascular insufficiency
I67.82
Cerebral ischemia
I67.83
Posterior reversible encephalopathy syndrome
I67.841
Reversible cerebrovascular vasoconstriction
syndrome
I67.848
Other cerebrovascular vasospasm and
vasoconstriction
I67.89
Other cerebrovascular disease
I67.9
Cerebrovascular disease, unspecified
I68.0
Cerebral amyloid angiopathy
I68.2
Cerebral arteritis in other diseases classified
elsewhere
I68.8
Other cerebrovascular disorders in diseases
classified elsewhere
O22.51
Cerebral venous thrombosis in pregnancy
unspecified trimester
O22.52
Cerebral venous thrombosis in pregnancy second
trimester
O22.53
Cerebral venous thrombosis in pregnancy third
trimester
O87.3
Cerebral venous thrombosis in the puerperium
I97.810
Intraoperative cerebrovascular infarction during
cardiac surgery
I97.811
Intraoperative cerebrovascular infarction during
other surgery
I97.820
Postprocedural cerebrovascular infarction during
cardiac surgery
I97.821
Postprocedural cerebrovascular infarction during
other surgery
13. Acute Heart Failure / Pulmonary edema
J81.0
I50.1
I50.20
I50.21
I50.23

Acute pulmonary edema
Left ventricular failure
Unspecified systolic (congestive) heart failure
Acute systolic (congestive) heart failure
Acute on chronic systolic (congestive) heart
failure
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I50.30
I50.31
I50.33

Unspecified diastolic (congestive) heart failure
Acute diastolic (congestive) heart failure
Acute on chronic diastolic (congestive) heart
failure
I50.40
Unspecified combined systolic (congestive) and
diastolic (congestive) heart failure
I50.41
Acute combined systolic (congestive) and
diastolic (congestive) heart failure
I50.43
Acute on chronic combined systolic (congestive)
and diastolic (congestive) heart failure
I50.9
Heart failure, unspecified
14. Severe anesthesia complications
O74.0
O74.1
O74.2
O74.3
O89.01
O89.09
O89.1
O89.2

Aspiration pneumonitis due to anesthesia during
labor and delivery
Other pulmonary complications of anesthesia
during labor and delivery
Cardiac complications of anesthesia during labor
and delivery
Central nervous system complications of
anesthesia during labor and delivery
Aspiration pneumonitis due to anesthesia during
the puerperium
Other pulmonary complications of anesthesia
during the puerperium
Cardiac complications of anesthesia during the
puerperium
Central nervous system complications of
anesthesia during the puerperium

15. Sepsis
O85
O86.04
T80.211A
T81.4XXA
T81.44XA
T81.44XD
T81.44XS
T81.44
R65.20
A40.0

Puerperal sepsis
Sepsis following an obstetrical procedure
Bloodstream infection due to central venous
catheter, initial encounter
Infection following a procedure, initial encounter
Sepsis following a procedure, initial encounter
Sepsis following a procedure, subsequent
encounter
Sepsis following a procedure, sequela
Sepsis following a procedure
Severe sepsis without septic shock
Sepsis due to streptococcus, group A
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A40.1
A40.3
A40.8
A40.9
A41.01
A41.02
A41.1
A41.2
A41.3
A41.4
A41.50
A41.51
A41.52
A41.53
A41.59
A41.81
A41.89
A41.9
A32.7
16. Shock

Sepsis due to streptococcus, group B
Sepsis due to Streptococcus pneumoniae
Other streptococcal sepsis
Streptococcal sepsis, unspecified
Sepsis due to Methicillin susceptible
Staphylococcus aureus
Sepsis due to Methicillin resistant Staphylococcus
aureus
Sepsis due to other specified staphylococcus
Sepsis due to unspecified staphylococcus
Sepsis due to Hemophilus influenza
Sepsis due to anaerobes
Gram-negative sepsis, unspecified
Sepsis due to Escherichia coli
Sepsis due to pseudomonas
Sepsis due to serratia
Other gram-negative sepsis
Sepsis due to Enterococcus
Other specified sepsis
Sepsis, unspecified
Listerial sepsis

O75.1
R57.0
R57.1
R57.8
R57.9
R65.21
T78.2XXA
T88.2XXA
T88.6XXA

Shock during or following labor and delivery
Cardiogenic shock
Hypovolemic shock
Other shock
Shock, unspecified
Severe sepsis with septic shock
Anaphylactic shock, unspecified
Shock due to anesthesia
Anaphylactic reaction due to adverse effect of
correct drug or medicament properly administered
T81.10XA
Postprocedural shock unspecified, initial
encounter
T81.11XA
Postprocedural cardiogenic shock, initial
encounter
T81.19XA
Other postprocedural shock, initial encounter
17. Sickle Cell Disease with Crisis
D57.00

Hb-SS disease with crisis, unspecified
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D57.01
D57.02
D57.211

Hb-SS disease with acute chest syndrome
Hb-SS disease with splenic sequestration
Sickle-cell/Hb-C disease with acute chest
syndrome
D57.212
Sickle-cell/Hb-C disease with splenic
sequestration
D57.219
Sickle-cell/Hb-C disease with crisis, unspecified
D57.411
Sickle-cell thalassemia with acute chest syndrome
D57.412
Sickle-cell thalassemia with splenic sequestration
D57.419
Sickle-cell thalassemia with crisis, unspecified
D57.811
Other sickle-cell disorders with acute chest
syndrome
D57.812
Other sickle-cell disorders with splenic
sequestration
D57.819
Other sickle-cell disorders with crisis, unspecified
18. Air and thrombotic embolism
I26.01
I26.02
I26.09
I26.90
I26.92
I26.99
O88.011
O88.012
O88.013
O88.019
O88.02
O88.03
O88.211
O88.212
O88.213
O88.219
O88.22
O88.23

Septic pulmonary embolism with acute cor
pulmonale
Saddle embolus of pulmonary artery with acute
cor pulmonale
Other pulmonary embolism with acute cor
pulmonale
Septic pulmonary embolism without acute cor
pulmonale
Saddle embolus of pulmonary artery without acute
cor pulmonale
Other pulmonary embolism without acute cor
pulmonale
Air embolism in pregnancy, first trimester
Air embolism in pregnancy, second trimester
Air embolism in pregnancy, third trimester
Air embolism in pregnancy, unspecified trimester
Air embolism in childbirth
Air embolism in the puerperium
Thromboembolism in pregnancy, first trimester
Thromboembolism in pregnancy, second trimester
Thromboembolism in pregnancy, third trimester
Thromboembolism in pregnancy, unspecified
trimester
Thromboembolism in childbirth
Thromboembolism in the puerperium
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O88.311

Pyemic and septic embolism in pregnancy, first
trimester
O88.312
Pyemic and septic embolism in pregnancy, second
trimester
O88.313
Pyemic and septic embolism in pregnancy, third
trimester
O88.319
Pyemic and septic embolism in pregnancy,
unspecified trimester
O88.32
Pyemic and septic embolism in childbirth
O88.33
Pyemic and septic embolism in the puerperium
O88.811
Other embolism in pregnancy first trimester
O88.812
Other embolism in pregnancy second trimester
O88.813
Other embolism in pregnancy third trimester
O88.819
Other embolism in pregnancy, unspecified
trimester
O88.82
Other embolism in childbirth
O88.83
Other embolism in the puerperium
PROCEDURE ICD-10
Descriptions
19. Blood transfusion
30230H0
30230K0
30230L0
30230M0
30230N0
30230P0
30230R0
30230T0
30230H1
30230K1
30230L1

Transfusion of Autologous Whole Blood into
Peripheral Vein, Open Approach
Transfusion of Autologous Frozen Plasma into
Peripheral Vein, Open Approach
Transfusion of Autologous Fresh Plasma into
Peripheral Vein, Open Approach
Transfusion of Autologous Plasma
Cryoprecipitate into Peripheral Vein, Open
Approach
Transfusion of Autologous Red Blood Cells into
Peripheral Vein, Open Approach
Transfusion of Autologous Frozen Red Cells into
Peripheral Vein, Open Approach
Transfusion of Autologous Platelets into
Peripheral Vein, Open Approach
Transfusion of Autologous Fibrinogen into
Peripheral Vein, Open Approach
Transfusion of Non-autologous Whole Blood into
Peripheral Vein, Open Approach
Transfusion of Non-autologous Frozen Plasma
into Peripheral Vein, Open Approach
Transfusion of Non-autologous Fresh Plasma into
Peripheral Vein, Open Approach
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30230M1
30230N1
30230P1
30230R1
30230T1
30233H0
30233K0
30233L0
30233M0
30233N0
30233P0
30233R0
30233T0
30233H1
30233K1
30233L1
30233M1
30233N1
30233P1
30233R1

Transfusion of Non-autologous Plasma
Cryoprecipitate into Peripheral Vein, Open
Approach
Transfusion of Non-autologous Red Blood Cells
into Peripheral Vein, Open Approach
Transfusion of Non-autologous Frozen Red Cells
into Peripheral Vein, Open Approach
Transfusion of Non-autologous Platelets into
Peripheral Vein, Open Approach
Transfusion of Non-autologous Fibrinogen into
Peripheral Vein, Open Approach
Transfusion of Autologous Whole Blood into
Peripheral Vein, Percutaneous Approach
Transfusion of Autologous Frozen Plasma into
Peripheral Vein, Percutaneous Approach
Transfusion of Autologous Fresh Plasma into
Peripheral Vein, Percutaneous Approach
Transfusion of Autologous Plasma
Cryoprecipitate into Peripheral Vein,
Percutaneous Approach
Transfusion of Autologous Red Blood Cells into
Peripheral Vein, Percutaneous Approach
Transfusion of Autologous Frozen Red Cells into
Peripheral Vein, Percutaneous Approach
Transfusion of Autologous Platelets into
Peripheral Vein, Percutaneous Approach
Transfusion of Autologous Fibrinogen into
Peripheral Vein, Percutaneous Approach
Transfusion of Non-autologous Whole Blood into
Peripheral Vein, Percutaneous Approach
Transfusion of Non-autologous Frozen Plasma
into Peripheral Vein, Percutaneous Approach
Transfusion of Non-autologous Fresh Plasma into
Peripheral Vein, Percutaneous Approach
Transfusion of Non-autologous Plasma
Cryoprecipitate into Peripheral Vein,
Percutaneous Approach
Transfusion of Non-autologous Red Blood Cells
into Peripheral Vein, Percutaneous Approach
Transfusion of Non-autologous Frozen Red Cells
into Peripheral Vein, Percutaneous Approach
Transfusion of Non-autologous Platelets into
Peripheral Vein, Percutaneous Approach
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30233T1
30240H0
30240K0
30240L0
30240M0
30240N0
30240P0
30240R0
30240T0
30240H1
30240K1
30240L1
30240M1
30240N1
30240P1
30240R1
30240T1
30243H0
30243K0
30243L0
30243M0

Transfusion of Non-autologous Fibrinogen into
Peripheral Vein, Percutaneous Approach
Transfusion of Autologous Whole Blood into
Central Vein, Open Approach
Transfusion of Autologous Frozen Plasma into
Central Vein, Open Approach
Transfusion of Autologous Fresh Plasma into
Central Vein, Open Approach
Transfusion of Autologous Plasma
Cryoprecipitate into Central Vein, Open Approach
Transfusion of Autologous Red Blood Cells into
CentralVein, Open Approach
Transfusion of Autologous Frozen Red Cells into
Central Vein, Open Approach
Transfusion of Autologous Platelets into Central
Vein, Open Approach
Transfusion of Autologous Fibrinogen into
Central Vein, Open Approach
Transfusion of Non-autologous Whole Blood into
Central Vein, Open Approach
Transfusion of Non-autologous Frozen Plasma
into Central Vein, Open Approach
Transfusion of Non-autologous Fresh Plasma into
Central Vein, Open Approach
Transfusion of Non-autologous Plasma
Cryoprecipitate into Central Vein, Open Approach
Transfusion of Non-autologous Red Blood Cells
into Central Vein, Open Approach
Transfusion of Non-autologous Frozen Red Cells
into Central Vein, Open Approach
Transfusion of Non-autologous Platelets into
Central Vein, Open Approach
Transfusion of Non-autologous Fibrinogen into
Central Vein, Open Approach
Transfusion of Autologous Whole Blood into
Central Vein, Percutaneous Approach
Transfusion of Autologous Frozen Plasma into
Central Vein, Percutaneous Approach
Transfusion of Autologous Fresh Plasma into
Central Vein, Percutaneous Approach
Transfusion of Autologous Plasma
Cryoprecipitate into Central Vein, Percutaneous
Approach
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30243N0
30243P0
30243R0
30243T0
30243H1
30243K1
30243L1
30243M1
30243N1
30243P1
30243R1
30243T1
30250H0
30250K0
30250L0
30250M0
30250N0
30250P0
30250R0
30250T0
30250H1

Transfusion of Autologous Red Blood Cells into
Central Vein, Percutaneous Approach
Transfusion of Autologous Frozen Red Cells into
Central Vein, Percutaneous Approach
Transfusion of Autologous Platelets into Centrall
Vein, Percutaneous Approach
Transfusion of Autologous Fibrinogen into
Central Vein, Percutaneous Approach
Transfusion of Non-autologous Whole Blood into
Central Vein, Percutaneous Approach
Transfusion of Non-autologous Frozen Plasma
into Central Vein, Percutaneous Approach
Transfusion of Non-autologous Fresh Plasma into
Central Vein, Percutaneous Approach
Transfusion of Non-autologous Plasma
Cryoprecipitate into Central Vein, Percutaneous
Approach
Transfusion of Non-autologous Red Blood Cells
into Central Vein, Percutaneous Approach
Transfusion of Non-autologous Frozen Red Cells
into Central Vein, Percutaneous Approach
Transfusion of Non-autologous Platelets into
Central Vein, Percutaneous Approach
Transfusion of Non-autologous Fibrinogen into
Central Vein, Percutaneous Approach
Transfusion of Autologous Whole Blood into
Peripheral Artery, Open Approach
Transfusion of Autologous Frozen Plasma into
Peripheral Artery, Open Approach
Transfusion of Autologous Fresh Plasma into
Peripheral Artery, Open Approach
Transfusion of Autologous Plasma
Cryoprecipitate into Artery Vein, Open Approach
Transfusion of Autologous Red Blood Cells into
Artery Vein, Open Approach
Transfusion of Autologous Frozen Red Cells into
Artery Vein, Open Approach
Transfusion of Autologous Platelets into Artery
Vein, Open Approach
Transfusion of Autologous Fibrinogen into Artery
Vein, Open Approach
Transfusion of Non-autologous Whole Blood into
Peripheral Artery, Open Approach
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30250K1
30250L1
30250M1
30250N1
30250P1
30250R1
30250T1
30253H0
30253K0
30253L0
30253M0
30253N0
30253P0
30253R0
30253T0
30253H1
30253K1
30253L1
30253M1
30253N1

Transfusion of Non-autologous Frozen Plasma
into Peripheral Artery, Open Approach
Transfusion of Non-autologous Fresh Plasma into
PeripheralArtery, Open Approach
Transfusion of Non-autologous Plasma
Cryoprecipitate into Peripheral Artery, Open
Approach
Transfusion of Non-autologous Red Blood Cells
into Peripheral Artery, Open Approach
Transfusion of Non-autologous Frozen Red Cells
into Peripheral Artery, Open Approach
Transfusion of Non-autologous Platelets into
Peripheral Artery, Open Approach
Transfusion of Non-autologous Fibrinogen into
Peripheral Artery, Open Approach
Transfusion of Autologous Whole Blood into
Peripheral Vein, Percutaneous Approach
Transfusion of Autologous Frozen Plasma into
Peripheral Artery, Percutaneous Approach
Transfusion of Autologous Fresh Plasma into
Peripheral Artery, Percutaneous Approach
Transfusion of Autologous Plasma
Cryoprecipitate into Peripheral Artery,
Percutaneous Approach
Transfusion of Autologous Red Blood Cells into
PeripheralArtery, Percutaneous Approach
Transfusion of Autologous Frozen Red Cells into
Peripheral Artery, Percutaneous Approach
Transfusion of Autologous Platelets into
Peripheral Artery, Percutaneous Approach
Transfusion of Autologous Fibrinogen into
Peripheral Artery, Percutaneous Approach
Transfusion of Non-autologous Whole Blood into
Peripheral Artery, Percutaneous Approach
Transfusion of Non-autologous Frozen Plasma
into Peripheral Artery, Percutaneous Approach
Transfusion of Non-autologous Fresh Plasma into
Peripheral Artery, Percutaneous Approach
Transfusion of Non-autologous Plasma
Cryoprecipitate into Peripheral Artery,
Percutaneous Approach
Transfusion of Non-autologous Red Blood Cells
into Peripheral Artery, Percutaneous Approach
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30253P1
30253R1
30253T1
30260H0
30260K0
30260L0
30260M0
30260N0
30260P0
30260R0
30260T0
30260H1
30260K1
30260L1
30260M1
30260N1
30260P1
30260R1
30260T1
30263H0
30263K0

Transfusion of Non-autologous Frozen Red Cells
into Peripheral Artery, Percutaneous Approach
Transfusion of Non-autologous Platelets into
Peripheral Artery, Percutaneous Approach
Transfusion of Non-autologous Fibrinogen into
Peripheral Artery, Percutaneous Approach
Transfusion of Autologous Whole Blood into
Central Artery, Open Approach
Transfusion of Autologous Frozen Plasma into
Central Artery, Open Approach
Transfusion of Autologous Fresh Plasma into
Central Artery, Open Approach
Transfusion of Autologous Plasma
Cryoprecipitate into Central Artery, Open
Approach
Transfusion of Autologous Red Blood Cells into
Central Artery, Open Approach
Transfusion of Autologous Frozen Red Cells into
Central Artery, Open Approach
Transfusion of Autologous Platelets into Central
Artery, Open Approach
Transfusion of Autologous Fibrinogen into
Central Artery, Open Approach
Transfusion of Non-autologous Whole Blood into
Central Artery, Open Approach
Transfusion of Non-autologous Frozen Plasma
into Central Artery, Open Approach
Transfusion of Non-autologous Fresh Plasma into
Central Artery, Open Approach
Transfusion of Non-autologous Plasma
Cryoprecipitate into Central Artery, Open
Approach
Transfusion of Non-autologous Red Blood Cells
into Central Artery, Open Approach
Transfusion of Non-autologous Frozen Red Cells
into Central Artery, Open Approach
Transfusion of Non-autologous Platelets into
Central Artery, Open Approach
Transfusion of Non-autologous Fibrinogen into
Central Artery, Open Approach
Transfusion of Autologous Whole Blood into
Central Artery, Percutaneous Approach
Transfusion of Autologous Frozen Plasma into
Central Artery, Percutaneous Approach
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30263L0

Transfusion of Autologous Fresh Plasma into
Central Artery, Percutaneous Approach
30263M0
Transfusion of Autologous Plasma
Cryoprecipitate into Central Artery, Percutaneous
Approach
30263N0
Transfusion of Autologous Red Blood Cells into
Central Artery, Percutaneous Approach
30263P0
Transfusion of Autologous Frozen Red Cells into
Central Artery, Percutaneous Approach
30263R0
Transfusion of Autologous Platelets into Centrall
Artery, Percutaneous Approach
30263T0
Transfusion of Autologous Fibrinogen into
Central Artery, Percutaneous Approach
30263H1
Transfusion of Non-autologous Whole Blood into
Central Artery, Percutaneous Approach
30263K1
Transfusion of Non-autologous Frozen Plasma
into Central Artery, Percutaneous Approach
30263L1
Transfusion of Non-autologous Fresh Plasma into
Central Artery, Percutaneous Approach
30263M1
Transfusion of Non-autologous Plasma
Cryoprecipitate into Central Artery, Percutaneous
Approach
30263N1
Transfusion of Non-autologous Red Blood Cells
into Central Artery, Percutaneous Approach
30263P1
Transfusion of Non-autologous Frozen Red Cells
into Central Artery Percutaneous Approach
30263R1
Transfusion of Non-autologous Platelets into
Central Artery, Percutaneous Approach
30263T1
Transfusion of Non-autologous Fibrinogen into
Central Artery, Percutaneous Approach
20. Cardio monitoring
Not carried forward (either very low frequency or imprecise usage)
21. Conversion of cardiac rhythm
5A2204Z
Restoration of Cardiac Rhythm, Single
Cardiac countershock with successful conversion
to sinus rhythm ICD-9: 99.61,2,4,9
5A12012
Performance of Cardiac Output, Single, Manual
22. Hysterectomy
0UT90ZZ
Resection of Uterus, Open Approach
0UT94ZZ
Resection of Uterus, Percutaneous Endoscopic
Approach
0UT97ZZ
Resection of Uterus, Via Natural or Artificial
Opening
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0UT98ZZ

Resection of Uterus, Via Natural or Artificial
Opening Endoscopic
0UT9FZZ
Resection of Uterus, Via Natural or Artificial
Opening With Percutaneous Endoscopic
Assistance
23. Operations on heart and pericardium
Not carried forward (either very low frequency or imprecise usage)
24. Temporary tracheostomy
0B110Z4
Bypass Trachea to Cutaneous, Open Approach
0B110F4
Bypass Trachea to Cutaneous with Tracheostomy
Device, Open Approach
0B113Z4
Bypass Trachea to Cutaneous, Percutaneous
Approach
0B113F4
Bypass Trachea to Cutaneous with Tracheostomy
Device, Percutaneous Approach
0B114Z4
Bypass Trachea to Cutaneous, Percutaneous
Endoscopic Approach
0B114F4
Bypass Trachea to Cutaneous with Tracheostomy
Device, Percutaneous Endoscopic Approach
25. Ventilation

5A1935Z
5A1945Z
5A1955Z

Respiratory Ventilation, Less than 24 Consecutive
Hours
Respiratory Ventilation, 24-96 Consecutive Hours
Respiratory Ventilation, Greater than 96
Consecutive Hours

* Centers for Disease Control and Prevention. Reproductive Health. Severe Maternal
Morbidity. Retrieved from https://safehealthcareforeverywoman.org/aim-data/
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Appendix B: List of Delivery Hospitalization Codes
Delivery Hospitalizations
MS-DRG
Diagnosis codes

Procedure codes

Exclusions
Diagnosis codes
(Abortion/ectopic/molar pregnancy)

Procedures codes
(Abortion/ectopic/molar pregnancy)

'765', '766', '767', '768', '774', '775'
'Z370', 'Z371', 'Z372', 'Z373', 'Z374',
'Z3750', 'Z3751', 'Z3752', 'Z3753', 'Z3754',
'Z3759', 'Z3760', 'Z3761', 'Z3762', 'Z3763',
'Z3764', 'Z3769', 'O80', 'O82'
'10D00Z0', '10D00Z1', '10D00Z2',
'10D07Z3', '10D07Z4', '10D07Z5',
'10D07Z6', '10D07Z7', '10D07Z8',
'10E0XZZ'

'O000', 'O001', 'O002', 'O008', 'O009',
'O010', 'O011', 'O019', 'O020', 'O021',
'O0281', 'O0289',
'O029', 'O030', 'O031', 'O032', 'O0330',
'O0331', 'O0332', 'O0333', 'O0334',
'O0335', 'O0336', 'O0337', 'O0338',
'O0339', 'O034', 'O035', 'O036', 'O037',
'O0380', 'O0381', 'O0382', 'O0383',
'O0384', 'O0385', 'O0386', 'O0387',
'O0388', 'O0389', 'O039', 'O045', 'O046',
'O047', 'O0480', 'O0481', 'O0482',
'O0483', 'O0484', 'O0485',
'O0486', 'O0487', 'O0488', 'O0489',
'O070', 'O071', 'O072', 'O0730', 'O0731',
'O0732', 'O0733', 'O0734',
'O0735', 'O0736', 'O0737', 'O0738',
'O0739', 'O074', 'O080', 'O081', 'O082',
'O083', 'O084', 'O085', 'O086',
'O087', 'O0881', 'O0882', 'O0883',
'O0889', 'O089'
'10A00ZZ', '10A03ZZ', '10A04ZZ',
'10A07Z6', '10A07ZW', '10A07ZX',
'10A07ZZ', '10A08ZZ'

